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I. INTRODUCTION 
After viewing several television commercials promoting a certain 
medical treatment and doing some related research on the Internet, 
a middle-aged man walks into his physician’s office and requests a 
prescription for an advertised “lifestyle” medication.1  He explains 
that he is going on a cruise with his girlfriend the following week and 
he needs the medication as soon as possible.  The doctor reminds the 
patient that he has been treating him for high blood pressure and 
this drug may cause him some severe problems, possibly even a heart 
attack.  The patient briefly considers the risks and then demands the 
drug anyway. 
The physician thinks to himself: “I just graduated from medical 
school with $250,000 of debt.  Amanda and I just opened this prac-
tice, and we can’t afford to alienate patients if we want to stay afloat.  
I can’t believe how much we’re paying in rent and salaries, and my 
family seems to think it’s time we start living like a ‘doctor’s family.’  
As a resident, I wouldn’t have given this guy this drug, but now I can’t 
afford to say no.  Besides, I’ve fully explained the risks—it’s his call.  
And the risks aren’t that high.  Plus, maybe his managed care plan 
will deem it medically unnecessary or impose a huge co-pay, and 
when he sees how much it’s going to cost him, he’ll just drop this 
idea.” 
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Law), Richard M. Gulbrandsen Sr. (Managing Partner, Skousen, Gulbrandsen & Pa-
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 1 This hypothetical could just as easily have focused on a middle-aged woman 
who walks into her physician’s office and requests an “improved appearance” medi-
cation. 
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What should the doctor do?  If a patient specifically requests a 
particular treatment, medical device, or diagnostic test, is properly in-
formed of all the associated risks, and is willing to assume those risks, 
does a physician nonetheless have a responsibility to refuse a request 
that the physician believes is not medically indicated? 
Until the middle of the twentieth century, a physician could and 
generally would decide unilaterally what was in the “best interest” of a 
patient and most likely would have refused these types of requests.2  
During the latter half of the twentieth century, however, patient ad-
vocates challenged this paternalistic approach and insisted that pa-
tients, not their doctors, should make treatment decisions.  But 
should physicians provide requested treatments even when the pa-
tient’s request is contrary to the physician’s medical judgment?  Fur-
thermore, should doctors be held liable if they fail to exercise inde-
pendent medical judgment when acceding to a request that poses a 
material risk to the patient? 
The answer to these questions is relatively unclear.  Neither 
courts nor scholars have given much attention to this issue.  The pri-
mary reason for this void is that this situation seldom arose until the 
1990s, even after the doctrine of informed consent gained formal rec-
ognition.  Patients generally did not know enough about medical 
care to ask for a specific form of treatment.  The proliferation of the 
Internet and the Food and Drug Administration’s (FDA) release of a 
Draft Guidance in 1997 permitting direct-to-consumer advertising 
(“DTCA”), however, have combined to provide patients with a wealth 
of information that they may not employ wisely and may be leading to 
a dramatic paradigmatic shift in the nature of the physician-patient 
relationship.  Patients today are far more likely to self-diagnose their 
ailments and to push for or insist upon certain medications or other 
medical products or procedures.3  Notwithstanding their physicians’ 
concerns about the wisdom of the patients’ views, these patients can 
place considerable pressure on physicians to order this treatment.  
 2 See infra Part II. 
 3 A recent report noted that between seventy-five and eighty percent of Internet 
users have looked online for health information and revealed that seventy-five per-
cent of online patients with a chronic condition “say their last health search affected 
a decision about how to treat an illness or condition.”  SUSANNAH FOX, PEW INTERNET 
& AM. LIFE PROJECT, THE ENGAGED E-PATIENT POPULATION: PEOPLE TURN TO THE 
INTERNET FOR HEALTH INFORMATION WHEN THE STAKES ARE HIGH AND THE CONNECTION 
FAST 2 (Aug. 26, 2008), available at http://www.pewinternet.org/pdfs/PIP_Health_ 
Aug08.pdf; see John Schwartz, Logging On for a Second (or Third) Opinion, N.Y. TIMES, 
Sept. 30, 2008, at F2.  Another recent report, however, debated whether patients are 
“swimming” in a sea of health information or “drowning” in it.  Tara Parker-Pope, 
You’re Sick. Now What? Knowledge Is Power, N.Y. TIMES, Sept. 30, 2008, at F1. 
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This pressure may become particularly salient when patients threaten 
to go to another doctor if their physicians do not comply with their 
demands, or when physicians operating under the “crush” of daily 
practice are unwilling or unable to take the time to engage patients 
in a discussion as to why the requested medical response is contrain-
dicated. 
This Article explores the nature of a physician’s obligation to re-
fuse to provide medically contraindicated treatment to an insistent 
patient, even at the risk of alienating and perhaps losing the patient 
to another (perhaps less ethical) physician.  Part II of this Article de-
tails the history of the physician-patient relationship, describing the 
impact of a shift from the “paternalistic” model to a “patient auton-
omy” model.  Parts III and IV discuss the widespread availability of 
medical information via the Internet and DTCA, respectively, and 
their impact on the physician-patient relationship.  Part V discusses 
physicians’ current responsibility, driven by the doctrine of informed 
consent, to involve patients in the decision-making process and to 
permit them to make treatment decisions for themselves, and exam-
ines whether informed consent adequately protects patients in a 
world of DTCA and the Internet. 
Part VI argues that physicians have an ethical and a correspond-
ing legal obligation to exercise independent medical judgment when 
a patient demands access to products and services that are not medi-
cally indicated, and discusses the appropriate legal standard associ-
ated with a failure to meet this obligation.4  Part VII explores the 
benefits for physicians, patients, and society as a whole of recognizing 
that physicians have a fiduciary duty to exercise independent medical 
judgment in response to a patient’s demand for a service that is not 
medically indicated.  This Article concludes that it is not enough for a 
physician to merely inform patients of the risks of requested medical 
services and products, but that a physician also has an affirmative 
ethical and legal obligation to exercise independent medical judg-
ment and to refuse to acquiesce to a patient’s request that is contrary 
to the doctor’s medical judgment—notwithstanding the patient’s “in-
formed” demand for that service or product. 
 4 It is beyond the scope of this Article to discuss the situation where a patient re-
quests a medical service that the physician believes is ethically—as opposed to medi-
cally—contraindicated (e.g., a request for an abortion). 
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II. HISTORY OF THE PHYSICIAN-PATIENT RELATIONSHIP 
Historically, the doctor-patient relationship has been founded 
upon the principle of beneficence, played out through the doctrine 
of medical paternalism.5  Medical paternalism eventually gave way to 
notions of patient autonomy during the twentieth century when it 
was determined that patients have the right to make their own treat-
ment decisions.6  As discussed below, some commentators are now 
arguing that the era of patient autonomy should, in turn, give way to 
a shared responsibility where both the physician and patient jointly 
exercise decision-making authority. 
A. Paternalism 
Medical paternalism can be defined as “an action taken by one 
person in the best interests of another without their consent.”7  Since 
the days of Hippocrates, doctors have been empowered to make deci-
sions for their patients.8  Jay Katz, in his landmark work on the physi-
cian-patient relationship, observed that giving patients the liberty to 
make their own treatment decisions “was never part of the ethos of 
medicine.”9  Another scholar has written that “[t]he doctor decided 
what was best for the patient, and the patient accepted the decision, 
usually without questioning, [without] understanding, or perhaps 
even [without] a real choice.”10 
Ancient Greeks, including Plato and Hippocrates, taught that 
patients should not play a part in the decision-making process.11  
They viewed such participation as unnecessary and counterproduc-
tive because the doctor and the patient presumably had the same ob-
 5 Charity Scott, Why Law Pervades Medicine: An Essay on Ethics in Health Care, 14 
NOTRE DAME J.L. ETHICS & PUB. POL’Y 245, 263 (2000). 
 6 Id. 
 7 David C. Thomasma, Beyond Medical Paternalism and Patient Autonomy: A Model of 
Physician Conscience for the Physician-Patient Relationship, 98 ANNALS OF INTERNAL MED. 
243, 244 (1983) (citing James F. Childress, Paternalism and Health Care, in MEDICAL 
RESPONSIBILITY: PATERNALISM, INFORMED CONSENT, AND EUTHANASIA 15, 27 (Wade L. 
Rovison & Michael S. Pritchard eds., 1979)). 
 8 JAY KATZ, THE SILENT WORLD OF DOCTOR AND PATIENT 1–2 (Johns Hopkins Univ. 
Press 2002) (1984). 
 9 Id. at 2. 
 10 Scott, supra note 5, at 263. 
 11 Julie M. Spanbauer, Breast Implants as Beauty Ritual: Woman’s Sceptre and Prison, 
9 YALE J.L. & FEMINISM 157, 187 (1997) (“‘Perform [these duties] calmly and adroitly, 
concealing most things from the patient while you are attending to him . . . revealing 
nothing of the patient’s future or present condition.’” (quoting 2 HIPPOCRATES, 
DECORUM 297 (W. Jones trans., 1967))). 
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jective: to heal the sick.12  The physician alone possessed the knowl-
edge and experience needed to make a medical decision, so a pa-
tient’s input was viewed as unnecessary.  In addition, ancient physi-
cians believed that a patient’s psychological well-being was critical to 
the healing process.  They thought it would be therapeutically coun-
terproductive for a patient to truly understand their compromised 
state of health and the risks that they faced, knowledge which in turn 
would jeopardize, limit, and s
The Corpus Hippocraticum went so far as to recognize a duty of 
deceit, which encouraged physicians to conceal the patient’s true 
condition—especially from the patient.13  Ancient healers justified 
manipulation of the patient by noting, as Socrates did, “the healing 
effects of fair words.”14  Ancient doctors believed optimism and con-
fidence were essential to the healing process.  According to Hippo-
crates, the therapeutic effect of encouraging words was so important 
that a good doctor should always “promise to cure what is curable 
and to cure what is incurable.”15  Needless to say, the patient had little 
role to play in deciding the course of treatment. 
This belief in the therapeutic importance of “fair words,” even 
when these “words” did not accurately reflect the patient’s condition, 
and the limited involvement of patients in treatment decisions, con-
tinued to pervade medical ethics centuries later.  In the words of 
ninth-century Jewish physician Isaac Israeli: “Reassure the patient and 
declare his safety even though you may not be certain of it, for by this 
you will strengthen his Nature.”16  The importance of optimism and 
the value of deceit continued to justify physicians’ paternalistic 
treatment of their patients. 
In addition to the therapeutic impact of limited disclosures and 
optimism, physicians also insisted that there was an intimate relation-
ship between God and doctors.  During the middle ages, Jewish, Ara-
bic, and Christian physicians asserted that God anointed doctors; 
therefore, any attempt to question the physician would be question-
ing God, which would be blasphemous.17  As a result, the paternalistic 
 12 KATZ, supra note 8, at 6. 
 13 Lori B. Andrews, The Right and Rite of Informed Consent, 21 LAW & SOC’Y REV. 
765, 766 (1987) (describing one aspect of medical paternalism as “concealing most 
things from the patient, while you are attending to him . . . turning his attention 
away from what is being done to him; . . . revealing nothing of the patient’s future or 
present condition”) (citation omitted). 
 14 KATZ, supra note 8, at 6. 
 15 Id. 
 16 Id. at 9. 
 17 Id. at 8–9. 
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model for physician-patient interactions was, if anything, stronger 
during medieval times than its more recent manifestations.18 
Paternalism continued to pervade the physician-patient relation-
ship throughout the seventeenth,19 eighteenth,20 and nineteenth cen-
turies.21  Until the middle of the twentieth century, doctors—and so-
ciety—viewed physicians as having an obligation to act in their 
patients’ best interests, with no duty to inform patients of their treat-
ment options.22 
A particularly striking judicial recognition of paternalism oc-
curred in John F. Kennedy Memorial Hospital v. Heston,23 where the New 
Jersey Supreme Court found that a physician was justified in ordering 
a blood transfusion even when a patient’s objections were based on a 
religious belief that this treatment would result in the eternal damna-
tion of the patient’s soul.24  The court stated, “When the [interests of 
 18 Danuta Mendelson, Historical Evolution and Modern Implications of Concepts of 
Consent to, and Refusal of, Medical Treatment in the Law of Trespass, 17 J. LEGAL MED. 1, 
15 (1996) (“The essential model of the covenantal physician-patient relationship 
based on a patient’s obedience and trust also was adopted by Moslem and Arabic-
speaking Jewish physicians who became the intellectual heirs, custodians, and trans-
lators of the works of Hippocrates, Aristotle, and Galen into Hebrew and Arabic.”). 
 19 KATZ, supra note 8, at 10–13. 
 20 Id. at 13–16.  Note that some scholars started to recognize the need to com-
municate with the patient, but the physician still made the final decision.  See Men-
delson, supra note 18, at 19 (“‘Every man has the right to speak where his life or his 
health is concerned . . . .  It becomes [the patient] to interpose with politeness, and 
deference to the judgment of the physician; it becomes [the physician] to hear what they 
have to say with attention.’” (quoting J. GREGORY, LECTURES ON THE DUTIES AND 
QUALIFICATIONS OF A PHYSICIAN 35 (1992) (1772)) (emphasis added)). 
 21 KATZ, supra note 8, at 16–25.  Mendelson defends physicians of this era by as-
serting that the decision to forego explanations was an expression of “professional 
honesty” because physicians at that time did not understand the “benefits and risks 
involved in a particular course of therapy.”  Mendelson, supra note 18, at 22–23.  
Nevertheless, even Mendelson admits that “modern bioethicists would describe [this] 
attitude as ‘paternalistic.’”  Id. at 22. 
 22 See RUTH R. FADEN ET AL., A HISTORY AND THEORY OF INFORMED CONSENT 100–01 
(1986) (“[B]efore the mid-twentieth century, the beneficence model . . . was the only 
operative model of the physician’s responsibility to the patient.”).  Others argue, 
however, that the seeds of informed consent existed long before the patient auton-
omy movement of the twentieth century.  See, e.g., Martin S. Pernick, The Patient’s Role 
in Medical Decisionmaking: A Social History of Informed Consent in Medical Therapy, in 3 
PRESIDENT’S COMM’N FOR THE STUDY OF ETHICAL PROBLEMS IN MED., MAKING HEALTH 
CARE DECISIONS: STUDIES ON THE FOUNDATIONS OF INFORMED CONSENT 1, 3 (Gov’t 
Printing Office, 1982) (“[T]ruth-telling and consent-seeking have long been part of 
an indigenous medical tradition, based on medical theories that taught that knowl-
edge and autonomy had demonstrably beneficial effects on most patients’ health.”). 
 23 279 A.2d 670 (N.J. 1971).  New Jersey later overruled the case to the extent 
that the court placed greater importance on the physician’s rights than the patient’s 
rights.  In re Conroy, 486 A.2d. 1209, 1224 (N.J. 1985). 
 24 Heston, 279 A.2d at 673. 
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a] hospital and staff are . . . pitted against the belief of the patient, we 
think it reasonable to resolve the problem by permitting the hospital 
and its staff to pursue their functions according to their professional 
standards.”25 
B. Patient Autonomy 
In 1914, in Schloendorff v. Society of New York Hospital,26 Justice Ben-
jamin Cardozo wrote, “Every human being of adult years and sound 
mind has a right to determine what shall be done with his own body; 
and a surgeon who performs an operation without his patient’s con-
sent commits an assault.”27  To assert that a physician dedicated to 
healing the sick could assault a patient in the course of providing 
care that was neither negligent nor willfully deficient was nothing 
short of remarkable at that time (a view shared by many physicians 
now as well) and marked a radical shift toward recognizing patients’ 
rights in the physician-patient relationship. 
The notion that patients should have the legal right to make 
their own decisions—and that doctors should obtain consent before 
performing invasive procedures—originated in contract law.28  In-
deed, it has been widely noted that the consent Justice Cardozo 
called for in Schloendorff “had its basis in the prominent and ancient 
legal principle of consent in contract law.”29 
Analyzing the physician-patient relationship as merely a contrac-
tual arrangement, however, ultimately proved to be inadequate.30  
Under a traditional contractual approach, the physician merely had 
to show that the patient gave his or her general consent for the 
treatment provided, even though the patient had not been told about 
 25 Id.  See also Martha S. Swartz, “Conscience Clauses” or “Unconscionable Clauses”:  
Personal Beliefs Versus Professional Responsibilities, 6 YALE J. HEALTH POL’Y L. & ETHICS 
269, 315 (2006). 
 26 105 N.E. 92 (N.Y. 1914). 
 27 Id. at 93. 
 28 See Bryan J. Warren, Comment, Pennsylvania Medical Informed Consent Law: A 
Call to Protect Patient Autonomy Rights by Abandoning the Battery Approach, 38 DUQ. L. 
REV. 917, 929 (2000) (“Originally, the sufficiency of information provided and the 
nature of the physician-patient relationship were examined under principles of con-
tract law.”); see also Wall v. Brim, 138 F.2d 478, 481 (5th Cir. 1943); Scott, supra note 
5, at 264 (“Since the early part of this century, the law has expressed society’s view 
that it was wrong—a violation of autonomy—to treat the patient without some kind 
of consent.”). 
 29 Warren, supra note 28, at 929. 
 30 See id. (noting that the bargaining asymmetry between physician and patient, 
and the doctor’s potential conflicts of interest are reasons for the unsatisfactory na-
ture of the contractual relationship). 
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potential treatment alternatives; only a “minimalist expression of 
autonomy” was required.31  General consent may be sufficient for 
contractual parties with equal bargaining power who possess similar 
insights into and information about a proposed contractual agree-
ment, but the knowledge disparity between a doctor and a patient 
can result in an enormous asymmetry between the two.32  Analyzing 
the formation and implications of a physician-patient relationship 
under a contractual framework proved insufficient because of this 
asymmetry, particularly when physicians’ potential conflicts of inter-
est33 began to be recognized.34  In addition, patients are typically sick, 
injured, or worried about their state of health and in no position to 
engage in a traditional bargaining process.  In other words, the phy-
sician and patient are not conducting an arms-length transaction in 
the traditional sense.35  Contract law provided insufficient protection 
for the under-informed, vulnerable, distracted, or anxious patient. 
Just as a rising tide raises all boats, the increased recognition of 
civil rights in the 1950s and 1960s permeated and enhanced a range 
of individual rights, including those of medical patients.36  Although 
at first glance they may seem unrelated, the civil rights movement 
dramatically impacted the physician-patient relationship by creating a 
social atmosphere in which Americans placed increased value on the 
rights of individuals, including those of medical patients.37  Authority 
was openly questioned—whether it was the authority exercised by 
state and local officials or by a local physician—and the concept of 
 31 Scott, supra note 5, at 264. 
 32 Id. 
 33 For example, the undisclosed financial interests of a physician who recom-
mends a course of treatment to enhance the income of the physician rather than to 
meet the medical needs of the patient can result in an inappropriate conflict of in-
terests.  See, e.g., Moore v. Regents of Univ. of Cal., 793 P.2d 479, 483 (Cal. 1990) 
(holding that a research physician has an obligation to disclose his financial interest 
in a course of treatment). 
 34 Warren, supra note 28, at 929.  As will be discussed in Part V, this asymmetry of 
information is one of the primary bases for courts finding that physicians have a fi-
duciary duty to their patients. 
 35 See Canterbury v. Spence, 464 F.2d 772, 782 (D.C. Cir. 1972) (“The patient’s 
reliance upon the physician is a trust of the kind which traditionally has exacted ob-
ligations beyond those associated with arms-length transactions.”). 
 36 Swartz, supra note 25, at 314–17 (“As the result of the growing consumer and 
civil rights movements of the 1950s and 1960s, the emphasis among both medical 
ethicists and the courts began to center on a model of medical decision-making that 
emphasized patient autonomy and self-determination, rather than physicians’ 
rights.”). 
 37 See Scott, supra note 5, at 265; see also FADEN ET AL., supra note 22, at 87 (“The 
issues raised by civil rights, women’s rights, the consumer movement, and the rights 
of prisoners and of the mentally ill often included health care components.”). 
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individual autonomy and rights rose to the forefront of social think-
ing. 
In the political and social climate of the 1950s and 1960s, the pa-
tient autonomy movement was born.  One scholar has gone so far as 
to describe the resulting rise in patient autonomy as “‘the greatest 
revolution of twentieth century American society.’”38  During this 
time, “Patients began to voice the ethical proposition, founded on 
the autonomy principle, that they, rather than the doctors, should 
have the ultimate authority to decide the course of their medical 
treatment.”39  In an attempt to secure this newfound “ultimate au-
thority,” patients turned to the American court system
The courts ultimately endorsed the position espoused by the pa-
tients, finding doctors liable if they failed to properly disclose signifi-
cant risks and obtain “informed consent” before initiating medical 
treatment.41  A California court first used the phrase “informed con-
sent” in 1957 in a case where a physician admitted that he failed to 
disclose the dangers of a surgical procedure to his patient, and the 
patient awoke from surgery paralyzed.42  The doctrine was affirmed 
and further explicated in the seminal case of Canterbury v. Spence,43 
where the court ruled that a physician has a duty to disclose to a pa-
tient the material risks associated with a proposed procedure that a 
reasonable patient would need to hear to make an informed deci-
sion.44  The informed consent requirement marked the culmination 
of the shift in the nature of the physician-patient relationship from a 
paternalistic approach to one that emphasizes patient autonomy.45 
Under the patient-autonomy model, patients make the ultimate 
decisions concerning their healthcare, although these decisions are 
“based on the physician’s description of the relative risks, benefits, 
and alternatives available.”46  To determine which procedures are in 
their best interest, patients are entitled to know their viable options 
 38 Swartz, supra note 25, at 314 (quoting Alan Meisel, Managed Care, Autonomy, 
and Decisionmaking at the End of Life, 35 HOUS. L. REV. 1393, 1397 (1999)). 
 39 Scott, supra note 5, at 265. 
 40 Id. 
 41 Id. at 265–66. 
 42 Salgo v. Leland Stanford Jr. Univ. Bd. of Trs., 317 P.2d 170, 181 (Cal. Ct. App. 
1957). 
 43 464 F.2d 772 (D.C. Cir. 1972). 
 44 Id. at 787 (“[A] risk is . . . material when a reasonable person, in what the phy-
sician knows or should know to be the patient’s position, would be likely to attach 
significance to the risk or cluster of risks in deciding whether or not to forego the 
proposed therapy.”). 
 45 Id.; see infra Part V.A for further discussion of the informed consent doctrine. 
 46 Swartz, supra note 25, at 316. 
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and the material risks and benefits associated with each option.47  The 
doctor is responsible for dispensing information; the patient is re-
sponsible for making the decisions. 
On its face, alarmists could view this shift as resulting in highly 
trained professionals being reduced to mere information conduits 
with little decision-making authority, their extensive knowledge and 
expertise utilized only to the extent desired by the patient.48  In prac-
tice, however, patients usually seek and follow their doctors’ treat-
ment recommendations, and the recognition of patient autonomy 
did not revolutionize the physician-patient relationship, nor did it 
dramatically change the nature of the interaction between physicians 
and patients.49  For example, although advance directives were and 
continue to be highly heralded as a means of preserving the decision-
making rights of patients, they have been found to have had a limited 
impact on medical decisions, notwithstanding that the Patient Self-
Determination Act of 1991 mandates that patients must be notified of 
their right to execute such a document prior to every hospital admis-
sion.50 
Nevertheless, the respect afforded patient autonomy in the latter 
half of the twentieth century did represent an important landmark: 
society and the courts emphasized that patients have the right to make 
their own medical decisions, even if they do not necessarily exercise 
it.  As one scholar has indicated, “Informed consent has become the 
legal and philosophical cornerstone of physician-patient relation-
ships.”51  From a doctrinal perspective, the pendulum of power in the 
physician-patient relationship may appear to have swung almost en-
tirely to the side of the patients, even if it is a right of patients that is 
infrequently exercised and even more rarely enforced.52 
 47 Scott, supra note 5, at 266. 
 48 Liana Fraenkel & Sarah McGraw, Participation in Medical Decision Making: The 
Patient’s Perspective, 27 MED. DECISION MAKING 533, 536 (2007) (reporting on patient 
interviews in which patients explain that they make the decision after receiving the 
relevant information and recommendations from the physician). 
 49 Simon N. Whitney et al., A Typology of Shared Decision Making, Informed Consent 
and Simple Consent, 140 ANNALS INTERNAL MED. 54, 56 (2004) (“Although patients 
have broad rights to make their own decisions, . . . many patients, for a variety of rea-
sons, choose to delegate decisional authority to their physicians.”). 
 50 Angela Fagerlin & Carl E. Schneider, Enough: The Failure of the Living Will, 
HASTINGS CENTER REPORT, Mar.–Apr. 2004, at 30, 30–31. 
 51 Jonathan D. Moreno, Arthur L. Caplan & Paul Root Wolpe, Informed Consent, in 
2 ENCYCLOPEDIA OF APPLIED ETHICS 687 (Ruth Chadwick ed., 2d ed. 1998). 
 52 Much of the concern about this perceived shift can be attributed to relatively 
unjustified assumptions by physicians regarding the impact of this doctrinal change.  
One prominent medical malpractice attorney has referred to lawsuits based on a 
failure to obtain informed consent as the “hobgoblins” of physicians.  Thomas E. Al-
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C. Shared Duty Between Doctor and Patient 
Some scholars argue that the pendulum has appropriately swung 
back to a more moderate position and that a shared decision-making 
model governs today’s physician-patient relationship.53  The terms 
used more recently to describe physician-patient relationships are 
“negotiation” and “concordance.”54  Such concepts signify a decision-
making process where both parties are actively involved.55 
Today, it is widely agreed that proper healthcare decision mak-
ing involves a detailed communication and exchange between pa-
tients and physicians: the patients share their symptoms, concerns, 
goals, personal and family history, and lifestyle; and the physicians 
share the risks, side effects, alternatives, and probable results of po-
tential treatment options.56  Neither of the parties can or should shirk 
their respective responsibilities. 
Indeed, “[i]n its purest form, there is a two way exchange of in-
formation, [with] both doctor and patient reveal[ing] treatment 
preferences, and both agree[ing] on the decision to implement.”57  
When making decisions, both the physician and the patient have ac-
cess to important and relevant information, but each also lacks vital 
information.  On the one hand, physicians understand the medical 
implications, consequences, and risks of various treatment options.  
Patients, however, know what is important to their lives, what they 
hope to accomplish, and which risks they are willing to take. 
bro, Former President, Virginia Trial Lawyers Association, Address at University of 
Virginia School of Law (Nov. 28, 2007).  Nevertheless, a deeply entrenched fear of 
being sued for a failure to obtain informed consent has resulted in informed consent 
forms becoming ubiquitous, notwithstanding that they are largely ignored by the pa-
tients required to complete them as a condition for obtaining medical treatment. 
 53 Sydney Morss Dy, Instruments for Evaluating Shared Medical Decision Making: A 
Structured Literature Review, 64 MED. CARE RESEARCH & REV. 623, 623 (2007) (describ-
ing the shared decision-making model). 
 54 Nicola Mead & Peter Bower, Patient-Centredness: A Conceptual Framework and Re-
view of the Empirical Literature, 51 SOC. SCI. & MED. 1087, 1090 (2000). 
 55 See Thomas L. Hafemeister, End-of-Life Decision Making, Therapeutic Jurisprudence, 
and Preventive Law: Hierarchical v. Consensus-Based Decision-Making Model, 41 ARIZ. L. 
REV. 329, 356 (1999) (“[M]any health care scholars and practitioners have promoted 
a consensus-based or shared decision-making model.”). 
 56 See, e.g., Ben A. Rich, Medical Paternalism v. Respect for Patient Autonomy: The More 
Things Change the More They Remain the Same, 10 MICH. ST. J. MED. & L. 87, 102–03 
(“[W]eighing the risks and benefits of any medical procedure or course of treatment 
involves the consideration of a certain amount of scientific information.  But it also 
involves important normative elements . . . .”). 
 57 Cathy Charles, Tim Whelan & Amiram Gafni, What Do We Mean by Partnership in 
Making Decisions About Treatment?, 319 BRIT. MED. J. 780, 781 (1999). 
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For example, a professional athlete with a particular injury may 
desire a type of treatment that is likely to involve considerable initial 
pain and discomfort and carries a high risk of long-term disability, 
but which will enable the athlete to compete at the highest level and 
receive enormous compensation for a few more years.  However, an 
office worker with the same injury may want to minimize both cur-
rent and future pain, with little concern that he or she may not be 
able to compete at the same level athletically as in the past.  Under 
the shared decision-making model, physicians explain alternative 
treatment options and offer their opinion as to which option is supe-
rior, while patients describe their individual circumstances and de-
sires and, in light of the available options, express their view on which 
option is best.58  Such a dialogue is believed to enhance the likeli-
hood of a successful and mutually embraced treatment.59  At the end 
of the day, they hopefully can and generally do agree on the proper 
course of treat
III. THE INTERNET AND ITS IMPACT ON  
PHYSICIAN-PATIENT RELATIONSHIPS 
While preparing for the day’s activities and watching a child don 
a pair of pants, a parent notices that the child’s right leg is an inch 
shorter than the left leg.  What is the parent’s first action?  Does the 
parent call the child’s pediatrician to set up an appointment?  Does 
the parent take the child straight to the emergency room?  Or does 
the parent first perform a quick Internet search to learn more about 
this condition?  A patient may similarly visit the Internet after pre-
scribed medication has not resolved back pain as quickly as hoped or 
after receiving an adverse diagnosis from a physician. 
Patients now regularly seek health information on the Internet 
and then use this information to treat or otherwise respond to a 
 58 JENNIFER C. JACKSON, TRUTH, TRUST AND MEDICINE 156 (2001) (“The relation-
ship between doctor and patient is based on the concept of partnership and collabo-
rative effort.  Ideally, decisions are made through frank discussion, in which the doc-
tor’s clinical expertise and the patient’s individual needs and preferences are shared 
to select the best treatment option.” (quoting ANN SOMMERVILLE, MEDICAL ETHICS 
TODAY: ITS PRACTICE AND PHILOSOPHY 1 (1993))). 
 59 See Richard L. Kravitz, Measuring Patients’ Expectations and Requests, 134 ANNALS 
INTERNAL MED. 881, 881 (2001) (“Meeting patients’ expectations produces greater 
satisfaction with care, which in turn is related to greater adherence to medical ad-
vice, less ‘doctor-shopping,’ and a lower propensity to sue for malpractice.”) (cita-
tions omitted).  Kravitz also cites four empirical studies to demonstrate that patients’ 
expectations are complex but can be determined by paying attention to the patients’ 
“expression of feelings, provision of explanatory models, personal stories, and behav-
iors suggesting unresolved conflicts.”  Id. at 886–87. 
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health concern, which may help them to decide whether and when to 
ask for the assistance of a physician and may also prepare them for 
any subsequent visit with a physician.60  In addition, as out-of-pocket 
costs and the number of individuals without adequate healthcare 
coverage grow,61 even more individuals are likely to turn to the Inter-
net for medical guidance in the hope of minimizing their healthcare 
expenses.  One recent study determined that over sixty percent of 
Internet users have searched for medical information online.62  A 
2004 Harris Interactive poll found an even higher number of Inter-
net users—seventy-four percent—have searched for medical informa-
tion.63  The bottom line is that Americans routinely use the Internet 
to gain information about their health. 
 60 Sonia W. Nath, Relief for the E-patient? Legislative and Judicial Remedies to Fill 
HIPAA’s Privacy Gaps, 74 GEO. WASH. L. REV. 529, 533 (2006). 
 61 See Reed Abelson, Health Care Costs Increase Strain, Studies Find, N.Y. TIMES, Sept. 
24, 2008, at C4 (“Two studies released [on September 24, 2008] provide further evi-
dence of the toll health care is increasingly placing on working families, even for 
those who have health insurance.  And as employees are paying more medical ex-
penses out of their own pockets, they are having a harder time coming up with the 
money.”); Lisa Girion, Ranks of Uninsured in U.S. Shrank in ’07: The Census Bureau Says 
the 2007 Decrease Is Mostly Due to Expanded Government Coverage for Children, L.A. TIMES, 
Aug. 27, 2008, at A-20 (reporting that the number of Americans without health in-
surance was 45.7 million in 2007 (15.3% of all Americans)); see also NAT’L COALITION 
ON HEALTH CARE, FACTS ON HEALTH INSURANCE COVERAGE 1 (2009) [hereinafter FACTS 
ON HEALTH INSURANCE], available at http://www.nchc.org/documents/Coverage%20 
Fact%20Sheet-2009.pdf (“Nearly 46 million Americans, or 18 percent of the popula-
tion under the age of 65, were without health insurance in 2007 . . . .”); id. at 2–3 
(“Employee spending for health insurance coverage . . . has increased 120 percent 
between 2000 and 2006.”) (citation omitted); id. at 4 (“A study found that 29 percent 
of people who had health insurance were ‘underinsured’ with coverage so meager 
they often postponed medical care because of costs.”) (citation omitted); Press Re-
lease, The Commonwealth Fund, Higher Costs and Stagnant Incomes Increase Fi-
nancial Burden of Health Care, at 1 (Jan. 8, 2008) [hereinafter Higher Costs and 
Stagnant Incomes], available at http://www.commonwealthfund.org/usr_doc/HA_ 
Financial_Burden_NewsRelease.pdf?section=4059 (“45.4 Million Americans in Fami-
lies Spending More than 10 Percent of After-Tax Income on Health Care in 2004—
Almost 6 Million More than in 2001.”). 
 62 Michael B. Eisen & Andy Gass, Public Access to Public Science: Recommendations for 
the California Stem Cell Institute’s Policies Regarding Grantee-Produced Journal Articles, 21 
BERKELEY TECH. L.J. 1177, 1182 (2006). 
 63 Humphrey Taylor & Robert Leitman, No Significant Change in the Number of “Cy-
berchondriacs”—Those Who Go Online for Health Care Information, HEALTH CARE NEWS, 
Apr. 12, 2004, at 1, available at http://harrisinteractive.com/news/newsletters/ 
healthnews/HI_HealthCareNews2004Vol4_Iss07.pdf.  The discrepancy between the 
two statistics can likely be explained by the year in which the study was performed.  
Every year, more and more people turn to the Internet for information.  FOX, supra 
note 3, at 1.  An even more recent study estimated that between seventy-five percent 
and eighty percent of Internet users have looked online for health information.  Id. 
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This use is particularly pronounced among individuals who are 
already receiving healthcare from a physician.  One study found that 
patients frequently use the Internet to search for specific medical 
conditions (sixty-three percent) or a certain medical treatment or 
procedure (forty-seven percent).64  Another study indicated that 
eighty percent of all patients go online, and that ninety percent of 
these patients have used the Internet to help understand their medi-
cal conditions.65 
Because patients routinely perform Internet searches to learn 
more about their condition or symptoms, it is worth considering what 
impact the Internet has on their healthcare decisions.66  In one study, 
respondents were asked various questions concerning the impact of 
the Internet on their interactions with their physicians.67  The study 
found that thirty-six percent of those who frequently use the Internet 
sometimes or often suggested a specific illness when visiting a physi-
cian.68  In contrast, only sixteen percent of patients who hardly ever 
use the Internet made similar suggestions.69  In addition, forty-five 
percent of frequent Internet users sometimes or often request a spe-
cific treatment, while only nineteen percent of “hardly ever” Internet 
users make similar requests.70  In other words, Internet users are 
more likely to actively seek to shape the course of diagnosis and 
treatment with their ph
The same study asked patients how they use information from 
physicians when making healthcare decisions.  The data showed that 
some patients still abdicate complete decision-making authority to 
their physicians: eight percent of patients relied entirely on physi-
 64 Nath, supra note 60, at 534. 
 65 Vinod Podichetty & David Penn, The Progressive Roles of Electronic Medicine: Bene-
fits, Concerns, and Costs, 328 AM. J. MED. SCI. 94, 96 (2004). 
 66 See The Increasing Impact of eHealth on Consumer Behavior, HEALTH CARE NEWS, 
June 26, 2001, at 1 [hereinafter Impact of eHealth], available at http://www. 
harrisinteractive.com/news/newsletters/healthnews/HI_HealthCareNews2001Vol1_ 
iss21.pdf (“As our . . . study revealed, those who use the Internet to explore health is-
sues report that the information they find online has an impact on how they manage 
their overall health and comply with prescribed treatments.”). 
 67 Id. 
 68 Id. at 2. 
 69 Id. 
 70 Id. 
 71 It is beyond the scope of this Article to determine whether a patient’s accessing 
the Internet for medical information leads to better or to worse care.  This Article 
only addresses—regardless of the source of the patient’s beliefs—whether obligations 
are imposed on a physician when a patient demands a specific course of care that is 
medically contraindicated. 
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cians for health decisions.72  In contrast, nine percent used online re-
sources to diagnose themselves and determine the proper treatment, 
and then to persuade their physicians to provide the treatment they 
sought.73  Most people fell somewhere in the middle: fifty-five percent 
relied on physicians to make healthcare decisions but used the Inter-
net to learn more about the physician’s diagnosis, and twenty-eight 
percent sought information online to present to and discuss with 
their doctor but still relied on the physician to make the ultimate de-
cision.74 
These results demonstrate that over ninety percent of patients 
still rely considerably (and some entirely) on their physicians for help 
and advice in making proper medical decisions.  For most patients, 
this is likely to be consistent with a collaborative decision-making 
process and, arguably, the help of the Internet is likely to result in 
more informed decisions.  Of concern, however, are the nine percent 
of patients who self-diagnose and who may, with the acquiescence of 
the physician, treat the physician as a mere vehicle for obtaining ser-
vices that they desire but that are medically contraindicated.  These 
individuals may demand medically inappropriate services and give 
physicians ultimatums to provide requested care or lose their busi-
ness.  The problem, as noted by one physician, is that the demanded 
care is not necessarily the proper care: “[Y]ou know the old lawyer’s 
[saying] about a person who represents himself has a fool for a cli-
ent?  That applies in medicine, too.”75 
IV. DTCA AND ITS IMPACT ON PHYSICIAN-PATIENT RELATIONSHIPS 
The marketing of medical products to consumers has a lengthy 
history.  Prior to the enactment of the Food and Drug Act of 1906, 
itinerant peddlers and other scam artists were free to advertise their 
“snake oil” and other self-proclaimed “miracle” cures directly to the 
public.76  In part to counteract these marketing abuses, the federal 
government established the FDA in 1906.77  The FDA was authorized 
to screen proposed medications for safety and efficacy and to review 
 72 Impact of eHealth, supra note 66, at 4. 
 73 Id. 
 74 Id. 
 75 Nancy K. Plant, Prescription Drug Promotion on the Internet: Tool for the Inquisitive or 
Trap for the Unwary?, 42 ST. LOUIS U. L.J. 89, 151–52 (1998). 
 76 See, e.g., Zachary T. Bloomgarden, American Diabetes Association Annual Meeting 
1999: Diabetes and Obesity, 23 DIABETES CARE 118, 123 (2000) (explaining that the use 
of “sanitized tapeworms” was widely advertised as an easy weight loss program in the 
early 1900s). 
 77 See Food and Drug Act of 1906, 21 U.S.C. §§ 1–26 (2006). 
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the marketing of medical products to ensure that the American pub-
lic was not deceived into purchasing untested or dangerous medica-
tions.78  The development of, potential profit from, and competition 
among medical products has increased dramatically in recent years, 
however, which in turn has driven a desire to market medical prod-
ucts much more extensively.  This desire led to calls from the pro-
moters of these products to allow direct advertising once more to the 
American public.79 
A. The FDA’s Relaxed Standards 
The FDA has permitted direct-to-consumer advertising since the 
early 1980s, yet until recently companies seldom utilized DTCA due 
to the costs and burdens of complying with FDA disclosure require-
ments.80  The FDA, among other things, required pharmaceutical 
companies to explain in considerable depth the risks associated with 
their products.81  This condition was based on the FDA’s assertion 
that it was vital for prospective patients to know the risks to which 
they were exposing themselves—which was entirely consistent with 
the notions of informed consent that dominated this era.82 
The FDA’s requirements were greatly relaxed in 1997 with the 
release of a Draft Guidance by the FDA.83  The FDA’s Draft Guidance 
 78 21 C.F.R. § 202 (2006); see Richard C. Ausness, Will More Aggressive Marketing 
Practices Lead to Greater Tort Liability for Prescription Drug Manufacturers?, 37 WAKE 
FOREST L. REV. 97, 100 (2002) (“[T]he FDA oversees the labeling and the advertising 
of prescription drugs.  The FDA also regulates the labeling of all medical devices and 
the advertising of ‘restricted’ medical devices.”). 
 79 Most developed countries, however, have withstood these calls.  New Zealand 
and the United States have been reported to be the only developed nations allowing 
DTCA.  Milt Freudenheim, Showdown Looms in Congress over Drug Advertising, N.Y. 
TIMES, Jan. 22, 2007, at C1. 
 80 See Jaclyn Carole Hill, Note, The Learned Intermediary Doctrine and Beyond: Explor-
ing Direct-to-Consumer Drug Advertising Liability in the New Millennium, 72 DEF. COUNS. J. 
362, 362 (2005). 
 81 Id. 
 82 Id. 
 83 Yonni D. Fushman, Case Comment, Perez v. Wyeth Labs, Inc.: Toward Creating 
a Direct-to-Consumer Advertisement Exception to the Learned Intermediary Doctrine, 80 B.U. L. 
REV. 1161, 1173–74 (2000); see also Sheryl Calabro, Note, Breaking the Shield of the 
Learned Intermediary Doctrine: Placing the Blame Where it Belongs, 25 CARDOZO L. REV. 
2241, 2270 (2004).  The FDA and Congress are currently considering reversing the 
1997 relaxation of the regulation of DTCA and “[i]n the face of this pressure, the 
pharmaceutical industry has voluntarily agreed to abstain from advertising a new 
drug within the first six months of its release.”  W. David Bradford et al., The Impact of 
DCA on the Use and Effectiveness of Statin Drugs, Presentation at the Conference of the 
American Society of Health Economists (June 5, 2006), http://healtheconomics.us/ 
conference/2006/abstracts/issues-in-the-promotion-and-advertising-of-medicines/the 
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marked a fundamental shift in the FDA’s policy on advertisements for 
prescription drugs and dramatically changed the restrictions on 
DTCA.  These guidelines noted the “inability of broadcast advertise-
ments of reasonable length to present and communicate effectively 
the extensive [disclosure] information” previously deemed necessary 
by the FDA to prevent patients from being inappropriately swayed by 
this marketing.84  As a result, currently a pharmaceutical company 
“merely has to identify the major side effects and ‘contraindications 
[of a medical product] in lay language during the broadcast.’”85  In-
stead of forcing companies to find a way to fully disclose the risks as-
sociated with their product, the FDA permits these advertisements to 
gloss over these risks by, for example, hiring an actor to speak very 
fast to convey a difficult to comprehend warning.86  As will be dis-
cussed, despite assertions from manufacturers that the information 
from these advertisements will improve medical decision making, ar-
guably the opposite has resulted. 
B. Prevalence of DTCA 
The effect of the FDA’s relaxed standards was an absolute flood 
of DTCA.  In 1996, the year before the FDA issued its Draft Guidance, 
pharmaceutical companies spent $595.5 million on DTCA.87  By 1999, 
following the FDA’s 1997 issuance of its Draft Guidance, DTCA 
_impact_of_dca_on_the_use_and_effectiveness_of_statin_drugs (last visited Mar. 20, 
2009). 
 84 Consumer-Directed Broadcast Advertisements, 62 Fed. Reg. 43,171 (Dep’t of 
Health & Human Servs. Aug. 12, 1997) (notice of draft guidance for industry). 
 85 Calabro, supra note 83, at 2270–71.  Specifically, in 1997 broadcast advertise-
ments were required to contain “(1) a toll-free number that provides more specific 
information about a drug; (2) an alternative means of dispensing package labeling 
for consumers not connected to the internet; (3) a statement directing consumers to 
pharmacists and/or physicians; and (4) an internet web page address with specific 
information about the drug.”  Fushman, supra note 83, at 1174.  The final version of 
the FDA’s draft guidance was issued in 1999, adding the requirement that broadcast 
advertisements “be accompanied by more extensive print ads.”  Id. 
 86 Lawmakers and others have criticized the FDA’s enforcement of DTCA regula-
tions.  See Julie M. Donahue, Marisa Cevasco & Meredith B. Rosenthal, A Decade of Di-
rect-to-Consumer Advertising of Prescription Drugs, 357 NEW ENG. J. MED. 673, 674 (2007) 
(citing Gov’t Accountability Office, Prescription Drugs: Improvements Needed in FDA’s 
Oversight of Direct-to-Consumer Advertising (November 2006)).  Since these criticisms, 
legislators have considered bills to place greater restrictions on DTCA.  See, e.g., 
David C. Vladeck, The Difficult Case of Direct-to-Consumer Drug Advertising, 41 LOY. L.A. 
L. REV. 259 (2008) (analyzing two proposals before Congress that would require dis-
claimers on DTCA and place a moratorium on the DTCA of certain medications); 
Matthew Perrone, Bill Could Block Some Ads for New Drugs, SFGATE.COM, Apr. 17, 2007, 
http://www.sfgate.com/cgi-bin/article.cgi?f=/n/a/2007/04/17/national/w083226D 
34.DTL&type (last visited Mar. 20, 2009). 
 87 Fushman, supra note 83, at 1170 n.60. 
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spending nearly quadrupled to a then-record $1.9 billion.88  The ex-
panded use of DTCA has continued during the ensuing years.  
Spending by pharmaceutical companies on DTCA reached $5.4 bil-
lion in 2006.89 
Companies are using television commercials, as well as virtually 
all other media outlets, to promote everything from antidepressant 
medications to specific surgical procedures.90  Medtronic Inc., for ex-
ample, spent $100 million on an advertising campaign to encourage 
consumers/patients to ask their doctors about the possible need for 
a surgically-implanted $30,000 heart defibrillator.91 
C. Effects of DTCA 
Proponents of DTCA—mostly pharmaceutical companies—
defend these expenditures as an important method to “raise aware-
 88 Id. 
 89 Linda A. Johnson, Consumer Drug Ads Down This Year, Report Says, 
USATODAY.COM, Nov. 14, 2008, http://www.usatoday.com/money/economy/2008-
11-14-4021946389_x.htm (last visited Mar. 20, 2009).  Spending is reported to have 
declined three percent in 2007 to $5.3 billion, a still sizeable sum, and to have de-
creased six percent over the first eight months of 2008.  Id.  This drop has been al-
ternatively attributed to fewer blockbuster drugs coming on the market, overall in-
dustry cost-cutting, “heat from lawsuits and critics claiming [drug company] ads 
overstate benefits and understate risks of some drugs,” and “the Food and Drug Ad-
ministration now requir[ing] a few drug companies to get preapproval before airing 
ads.”  Id.  Despite this diminishment, concerns about the adverse impact of DTCA 
continue to proliferate.  See Dingell, Stupak Send Five Letters Regarding Questionable DTC 
Advertising of Prescription Drugs, 6(40) HEALTH LAW WKLY. (Oct. 17, 2008), available at 
http://www.healthlawyers.org/News/Health%20Lawyers%20Weekly/Pages/2008/O
ctober%202008/October%2017%202008/Dingell,StupakSendFiveLettersRegarding 
QuestionableDTCAdvertisingOfPrescriptionDrugs.aspx (“Congressman John D. 
Dingell (D-MI), Chairman of the Committee on Energy and Commerce, and Bart 
Stupak (D-MI), Chairman of the Oversight and Investigations Subcommittee, sent 
five letters October 14[, 2008,] in furtherance of their investigation into direct-to-
consumer (DTC) advertising of prescription drugs.”); Bruce Japsen, Medical Ads Aim 
Straight for the Heart, CHI. TRIB., Jan. 23, 2007, at C1; Francesca L. Kritz, Promises, Prom-
ises: As Efforts to Rein in TV Ads for Drugs Have Stumbled, Experts Worry That Too Many of 
Them Go Unchecked, L.A. TIMES, Feb. 11, 2008, at F-3. 
 90 See, e.g., Marshall H. Chin, The Patient’s Role in the Choice of Medications: Direct-to-
Consumer Advertising and Patient Decision Aids, 5 YALE J. HEALTH POL’Y L. & ETHICS 771, 
772 n.5 (2005) (noting that DTCA markets drugs directly to consumers through tele-
vision, newspapers, magazines, direct mail, and the Internet); David M. Fritch, Should 
the Purple Pill by Any Other Drug Company Still Be as Purple? The Changing Face of Trade 
Dress Protection for Pharmaceutical Manufacturers, 47 IDEA 171, 188 (2006) (describing 
the “marketing blitz” of the drug Prilosec on television, the Internet, and print ads); 
Louis Boyarsky, Note, Stealth Celebrity Testimonials of Prescription Drugs: Placing the Con-
sumer in Harm’s Way and How the FDA Has Dropped the Ball, 28 LOY. L.A. ENT. L. REV. 
101, 102 (2008) (noting pharmaceutical companies’ use of celebrity talk shows to ad-
vertise their products). 
 91 Japsen, supra note 89. 
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ness” of medical conditions and the availability of related medical 
treatments.92  Critics, however, insist that the purpose—and effect—
of DTCA is to sell drugs and other medical products, not to inform 
the public.  These critics claim the advertisements misinform pa-
tients, not to mention enhance healthcare costs.93  Even the former 
Commissioner of the FDA, David Kessler, who oversaw the implemen-
tation of the revised guidelines of the FDA, seems to regret the FDA’s 
decision, stating that direct-to-consumer ads “do not effectively or 
consistently convey important information about product risks and 
benefits.”94 
Regardless of whether DTCA benefits society by increasing 
awareness of medical conditions and treatments, or harms society by 
misinforming and misleading patients into pursuing unduly expen-
sive and unneeded medical products, an important question to ad-
dress is whether DTCA is indeed having the effect its producers in-
tend.  Specifically, are patients requesting, and in some cases 
insisting, on particular medical products and services after viewing 
these advertisements, and is the medical judgment of physicians 
compromised as a result of the pressure they feel to order them?  
Various studies give reason for concern. 
A 1998 study found that sixty-three percent of patients requested 
a specific prescription medication by name.95  Another study, how-
ever, found that only thirty percent of patients knew which drug they 
wanted before walking into a doctor’s office, with forty percent of 
them receiving the requested drug.96  But even this more conservative 
 92 Id.  One Medtronic executive goes so far as to say, “This is about trying to save 
more lives. . . . There are people dying every day because they are not protected and 
they do not know they have a problem.”  Id. 
 93 Id.; see Rita Rubin, Analysis: Prescription Drug Ads Leave Out Risks, Alternatives, 
USA TODAY, Jan. 30, 2007, at D7.  Although critics of DTCA have focused on their 
promotion of pharmaceuticals, concerns have also been raised about the use of 
DTCA to promote medical devices.  Barry Meier, Consumer Ads for Medical Devices Sub-
ject of Senate Panel, N.Y. TIMES, Sept. 16, 2008, at C12 (“As makers of medical devices 
like artificial knees and heart stents increasingly pitch their products directly to con-
sumers, some lawmakers, medical groups, and others are calling for restrictions on 
such advertisements, claiming they mislead patients.”); Emily P. Walker, Medical De-
vice Direct-to-Consumer Ads Said to Need More FDA Oversight, MEDPAGE TODAY, Sept. 20, 
2008, http://www.medpagetoday.com/PublicHealthPolicy/HealthPolicy/10989 (last 
visited Mar. 20, 2009) (“The FDA should expand its oversight of direct-to-consumer 
ads to include medical devices, a prominent orthopedic surgeon and cardiologist 
told a congressional panel here this week.”). 
 94 Rubin, supra note 93. 
 95 Fushman, supra note 83, at 1171. 
 96 Id.  But see Meredith B. Rosenthal et al., Promotion of Prescription Drugs to Con-
sumers, 346 NEW ENG. J. MED. 498, 504 (2002) (referring to an international study that 
found that twenty-five percent of patients initiated conversations with their physicians 
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finding indicates that twelve percent of patients requested and re-
ceived specific prescription drugs from their physicians. 
Furthermore, as described below, DTCA seems to result in in-
creased prescriptions and pressures for those prescriptions, creates 
the potential for unwarranted prescribing of medications notwith-
standing the risks they may impose, and appears to augment health-
care costs. 
1. Increase in Prescriptions 
Perhaps not surprising in light of the significant investment in 
DTCA, studies strongly indicate that DTCA does in fact increase the 
use of the advertised product.97  For example, in a nationally repre-
sentative telephone survey conducted in January 2008 by the Harvard 
School of Public Health, Kaiser Family Foundation, and USA Today, 
ninety-one percent of the adults contacted said they had heard or 
seen DTCA and thirty-two percent said they had discussed the adver-
tised drugs with their physicians.98  Furthermore, of those who talked 
to their doctor about an advertised drug, forty-four percent were 
given a prescription for that drug.99 
Similarly, the American Medical Association (AMA) conducted a 
randomized trial to determine “the effects of patients’ DTCA-related 
requests on physicians’ initial treatment decisions.”100  While portray-
ing symptoms of either a major depressive disorder or an adjustment 
disorder during their appointments with a physician, patients made a 
general request (that is, a particular type of medication was requested 
but a brand-specific request was not made), a brand-specific request, 
or did not request medication.101  The study found that patients who 
requested medication were much more likely to receive a medication 
than patients who made no such request.102  Furthermore, fifty-five 
concerning drugs they saw on television, and just under six percent actually received 
the prescription). 
 97 See, e.g., Vladeck, supra note 86, at 270 (describing a National Institute for 
Health Care Management study that found that the number of prescriptions for the 
fifty most advertised drugs rose 24.6% from 1999 to 2000). 
 98 USA TODAY, KAISER FAMILY FOUND. & HARV. SCH. OF PUB. HEALTH, THE PUBLIC 
ON PRESCRIPTION DRUGS AND PHARMACEUTICAL COMPANIES 4 (2008), available at 
http://www.kff.org/kaiserpolls/upload/7748.pdf. 
 99 Id.  In addition, these conversations were likely to result in the physician pre-
scribing at least some medication, with eighty-two percent of these patients receiving 
the drug they asked about or some other prescription.  Id. 
 100 Richard L. Kravitz et al., Influence of Patients’ Requests for Direct-to-Consumer Adver-
tised Antidepressants: A Randomized Controlled Trial, 293 JAMA 1995, 1995 (2005). 
 101 Id. at 1996. 
 102 Id. at 2000. 
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percent of patients who presented with an adjustment disorder and 
made a brand-specific request linked to DTCA received this prescrip-
tion, compared to only ten percent of those who did not make such a 
request.103  In other words, patients in this category were five times 
more likely to receive a given medication if they specifically requested 
it.  With regard to patients who portrayed major depression, 
“[a]ntidepressant prescribing rates were highest for visits in which 
[patients] made general requests for medication (76%), lowest for 
visits in which [patients] made no medication request (31%), and in-
termediate for visits in which [patients] made brand-specific requests 
linked to DTC advertising (53%[)].”104  The study concluded that 
“DTC advertisement-driven requests (along with general requests) 
dramatically boost prescribing.”105 
A study on the impact of DTCA on osteoarthritis medications 
similarly found that such advertising led to an increase in the pre-
scribing of these medications.106  Specifically, the DTCA produced by 
pharmaceutical giants Merck and Pfizer significantly increased the 
number of Vioxx prescriptions.107  The researchers found that Vioxx 
DTCA also had a significant effect on the number of physician vis-
its.108  The study concluded that DTCA increased the rate at which 
advertised medications were prescribed.109
Supporters of DTCA argue that increased levels of prescriptions 
resulting from DTCA lead to more informed patients, improved di-
agnoses, and possibly even increased adherence to doctors’ recom-
mendations.110  Supporters further claim that the ads may lead to 
heightened awareness of under-treated, under-diagnosed condi-
tions.111 
 103 Id. at 1998. 
 104 Id. 
 105 Id. at 2000. 
 106 W. David Bradford et al., How Direct-to-Consumer Television Advertising for Os-
teoarthritis Drugs Affects Physicians’ Prescribing Behavior, 25 HEALTH AFFAIRS 1371, 1376 
(2006). 
 107 Id  The study was performed in 2000.  Merck withdrew Vioxx from the market 
in September 2004 due to evidence of increased risk of heart attacks and stroke asso-
ciated with its use.  Id. at 1372. 
 108 Id. at 1375.  But note that Celebrex advertising had little effect on the number 
of Celebrex prescriptions.  Id. 
 109 Id. at 1376. 
 110 See Rosenthal et al., supra note 96, at 504. 
 111 Rob Stein, Marketing the Illness and the Cure?: Drug Ads May Sell People on the Idea 
That They Are Sick, WASH. POST, May 30, 2006, at A3. 
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Critics respond, however, that many of the ensuing prescriptions 
are unnecessary and even dangerous.112  Adverse effects from pre-
scription medication in general are the leading cause of iatrogenic in-
jury and death, claiming more victims than car accidents, illegal 
drugs, or diabetes.113  Given the risks associated with prescription 
medications and their respective side effects, doctors should, at a 
minimum, thoroughly explore and consider the need for and likely 
impact of any medication or other form of medical treatment before 
complying with the requests of patients for a given treatment re-
gime.114 
2. Inappropriate Treatment 
One commentator noted that “[t]he potential costs [of DTCA] 
are inappropriate prescribing driven by the demands of misinformed 
patients and time wasted by physicians in explaining why a particular 
therapy or product is not appropriate.”115  The AMA maintains that 
DTCA creates demand based on wants rather than needs, which can 
lead to “disease-mongering.”116 
Disease-mongering has been described as “taking [a condition] 
that is within normal bounds and labeling it a disease needing phar-
maceutical treatment.”117  Television, Internet, and print ads for a 
new drug manufactured to treat restless leg syndrome, for example, 
have been criticized as creating “disease-mongering” among normal, 
healthy individuals.118  Critics of these ads worry that people who sim-
ply have a hard time sitting still will request and receive an inappro-
priate prescription medication.119  In general, as one medical scholar 
explains, “[t]he ordinary experiences of life become a diagnosis, 
 112 See Devin Taylor, Note, Importing a Headache for Which There’s No Medicine: Why 
Drug Reimportation Should and Will Fail, 15 J.L. & POL’Y 1421, 1467 (2007). 
 113 See Jason Lazarou et al., Incidence of Adverse Drug Reactions in Hospitalized Patients, 
279 JAMA 1200, 1204 (1998).  This study published in the Journal of the American 
Medical Association (JAMA) found that adverse drug reactions “may rank from the 
fourth to sixth leading cause of death” in the United States, following heart disease, 
cancer, and stroke.  Id. 
 114 What distinguishes prescription medications from the over-the-counter drugs is 
that they have been established to carry a certain level of risk in addition to the bene-
fit they may provide. 
 115 See Rosenthal et al., supra note 96, at 504. 
 116 Japsen, supra note 89.  Sick people demanding medication is also a serious con-
cern.  They may as a result not be receiving the treatment they need, as well as poten-
tially suffering possible side effects from the treatment they do receive. 
 117 Stein, supra note 111. 
 118 Id. 
 119 Id. 
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which makes healthy people feel like they’re sick.”120  By definition, a 
medication that requires a prescription carries with it a risk of delete-
rious side effects.121  If healthy patients demand and receive prescrip-
tion medication, they unnecessarily incur the risks and side effects as-
sociated with the drugs, as well as simultaneously increasing 
healthcare costs for the rest of society. 
3. Increase in Healthcare Costs 
Unlike most non-medical products, prescription medications 
and other medical treatments are paid for largely by employers, in-
surance companies, and society.  Although out-of-pocket costs have 
increased, patients still pay a relatively small percentage of the costs 
of their healthcare.122  Because patients have few incentives to limit 
expenditures and society as a whole is largely left holding the bill for 
prescribed medications (as well as other medical treatments), the ad-
vent of DTCA and the resulting increased number of prescriptions or 
other medical treatments administered may inevitably lead to in-
creased healthcare costs for all.  Following the FDA’s relaxation of its 
restrictions on DTCA, for example, some insurers reported double-
digit increases in prescription costs.123 
D. DTCA’s Impact on the Physician-Patient Relationship 
When paternalism was the controlling principle governing the 
physician-patient relationship, patients simply followed the instruc-
tions of their doctor.  Forty years ago, it was rare for a patient to con-
tact a doctor and demand a certain medication or treatment.  In gen-
eral, patients would not even have known which medication to 
request. 
With the advent of DTCA, the Internet, and the patient auton-
omy movement, patients now frequently diagnose themselves and de-
cide upon a needed course of treatment before contacting their phy-
sician.  As one commentator noted, “Where once patients relied on 
doctors to decide which drugs to treat an ailment, now patients have 
 120 Id. 
 121 See supra notes 112–13 and accompanying text. 
 122 FACTS ON HEALTH INSURANCE, supra note 61, at 2 (“nearly 15 percent of em-
ployees had no employer-sponsored health coverage available to them, either 
through their own job or through a family member”); Higher Costs and Stagnant In-
comes, supra note 61, at 2 (reporting that the share of total health spending paid for 
out-of-pocket was 33.6% in 2004).  These out-of-pocket costs can nevertheless be con-
siderable for a given individual and are generally increasing, but they still remain 
only a fraction of the total healthcare bill.  See supra note 61 and accompanying text. 
 123 Japsen, supra note 89. 
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foreknowledge of the drugs they want and go to doctors as one would 
go to any vendor.”124 
This patient insistence on a course of treatment can have a sig-
nificant impact on physicians.  One study found that ninety percent 
of doctors reported feeling pressured to prescribe certain medica-
tions, eighty percent assented to patient requests, and thirty-one per-
cent admitted to prescribing drugs that were not their first choice.125  
Similarly, it has been reported that “71 percent of family physicians 
believe that direct-to-consumer advertising pressures physicians into 
prescribing drugs that they would not ordinarily prescribe.”126  Such 
findings have led “[c]ritics [to] despair that direct-to-consumer adver-
tising causes physicians to waste valuable time during encounters with 
patients and encourages the use of expensive and sometimes unnec-
essary medications.”127  These critics assert that “consumer-directed 
advertisements are having their intended effect—consumers are ask-
ing their doctors for the advertised products and doctors are re-
sponding positively.”128 
Increased patient requests for medication due to DTCA and in-
formation available on the Internet129 can create an atmosphere in 
which physicians feel pressured to acquiesce to their patients’ re-
quests rather than employ their own medical judgment.  This atmos-
phere is potentially injurious to patients and physicians alike.  Physi-
cians should always provide clinical advice and order treatment that is 
consistent with their medical judgment,130 and they should not be al-
lowed to abdicate this responsibility, even in the face of direct pres-
sure from the patient. 
The allure of succumbing to patient pressure becomes more ap-
parent when one considers the financial pressures that physicians 
face today.  Managed care organizations require physicians to hold 
down costs;131 immense overhead is associated with, among other 
 124 Fushman, supra note 83, at 1171. 
 125 Id. at 1172. 
 126 Rosenthal et al., supra note 96, at 498 (citing M.S. Lipsky & C.A. Taylor, The 
Opinions and Experiences of Family Physicians Regarding Direct-to-Consumer Advertising, 45 
J. FAM. PRACT. 495, 495–99 (1997)). 
 127 Id. 
 128 Teresa Moran Schwartz, Consumer-Directed Prescription Drug Advertising and the 
Learned Intermediary Rule, 46 FOOD DRUG COSM. L.J. 829, 844 (1991). 
 129 See supra notes 97–109 and accompanying text. 
 130 Note that the concerns identified in this Article do not arise when a patient 
chooses or suggests a viable treatment plan that coincides with the physician’s medi-
cal judgment, even if it is not the physician’s first choice. 
 131 See, e.g., John P. Little, Note, Managed Care Contracts of Adhesion: Terminating the 
Doctor-Patient Relationship and Endangering Patient Health, 49 RUTGERS L. REV. 1397, 
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things, maintaining state-of-the-art healthcare facilities and adhering 
to strict record-keeping requirements;132 the need for revenue places 
greater pressure to sustain and increase “patient flow”—that is, to 
process a given number of patients within a given allotted period of 
time;133 and the federal government deeply discounts payments for 
services provided to Medicare, Medicaid, and other government-
funded patients.134  In addition, physicians are subject to financial 
pressures from their own expectations and needs, as well as those of 
their spouses and children, who often feel entitled to a nice home, 
expensive vacations, and a high standard of living after sacrificing for 
many years during their medical training.135  These financial stresses 
are only compounded by physicians’ potentially astronomical student 
loans, which can be the equivalent of a home mortgage, or other 
forms of accumulated debt.136  As a result, physicians often feel pres-
sure to satisfy and retain patients as if they were customers in a retail 
business.137  Nevertheless, physicians must resist these financial pres-
1402 (1997) (“Financial penalties and the threat of being terminated from an MCO 
network provide strong incentives for physicians to restrict medical care . . . .”). 
 132 See, e.g., Deborah J. Meyers, Are You Hip with HIPAA? The Health Insurance Port-
ability and Accountability Act Is in Place to Benefit Employees, but Comes with Some High 
Costs to Employers, ALASKA BUS. MONTHLY, Mar. 1, 2003, available at 
http://www.allbusiness.com/human-resources/benefits-insurance-health/488237-
1.html (“One of the downsides of HIPAA is the increased cost . . . .”).  See generally 
Peggy Peck, Survey Reveals Large Numbers of Practicing Physicians Ready to Call It Quits, 
MEDPAGE TODAY, Nov. 18, 2008, http://www.medpagetoday.com/PublicHealthPolicy 
/HealthPolicy/11823 (reporting that “only 17% [of practicing physicians] said their 
practices were financially healthy and profitable”). 
 133 John D. Blum, The Evolution of Physician Credentialing into Managed Care Selective 
Contracting, 22 AM. J.L. & MED. 173, 185 (1996). 
 134 COMM. ON PEDIATRIC EMERGENCY MED., AMERICAN ACAD. OF PEDIATRICS, OVER-
CROWDING CRISIS IN OUR NATION’S EMERGENCY DEPARTMENTS: IS OUR SAFETY NET 
UNRAVELING?, 114 PEDIATRICS 878, 879 (2004) (“This incredible economic burden 
[for physicians and hospitals] is exacerbated by insufficient Medicare reimburse-
ment, which frequently fails to cover the direct costs of either the hospital facility or 
the emergency physician.”); Peck, supra note 132 (finding that sixty-six percent of 
practicing physicians said “Medicaid doesn’t pay enough to cover the cost of provid-
ing care and 36% said the same of Medicare”). 
 135 See Jacob Goldstein, As Doctors Get a Life, Strains Show: Quest for Free Time Reshapes 
Medicine; A Team Approach, WALL ST. J., Apr. 29, 2008, at A1 (“63% of medical resi-
dents said the availability of free time was causing them a ‘significant level of con-
cern’ as they entered the profession, up from 15% in 2001.”). 
 136 Editorial, Repair Student Loan Repayment Now: A Federal Legislative Change in How 
Medical School Graduates Repay Their Loans Leaves Residents in a Financial Pinch, AM. 
MED. NEWS, Nov. 19, 2007, available at http://www.ama-assn.org/amednews/2007/11 
/19/edsa1119.htm (“Medical school graduates carry an average of $130,571 in 
debt.”). 
 137 This analogy to the commercial world and the forces of the “market” is being 
compounded by the recent trend to make available to prospective medical care con-
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sures and provide treatment and services that reflect their medical 
judgment—even when faced with patients threatening to take their 
“business” elsewhere. 
Physicians also should not abdicate their all-important responsi-
bility of exercising sound medical judgment just because they are not 
fully informed about a patient’s condition and have limited time 
available to do related research.  Richard Kravitz explains, 
“[P]hysicians don’t know much about [certain illnesses] and may be 
wanting to follow the path of least resistance [i.e., acquiesce to the 
patient’s request] and prescribe a medication for a condition that a 
patient might not have.”138 
Whether physicians are following the “path of least resistance,” 
trying to maintain physician-patient relationships for fiscal purposes, 
or simply abdicating decision-making responsibility to their patients, 
studies indicate that some physicians inappropriately assent to patient 
demands.139  Due to DTCA and the Internet, patients often now be-
lieve they are informed regarding the appropriate course of treatment, 
so they enter the doctor’s office seeking a specific treatment rather 
than medical advice.  At times, patients may act as though they have 
already received an examination and diagnosis, and all that is needed 
is the physician’s signature to receive a particular treatment.140  Even 
when patient autonomy was at its zenith under the doctrine of in-
formed consent, the physician was nonetheless expected to be the 
one recommending a course of treatment, with the patient deciding 
among proffered options.  In the current era of DTCA and the Inter-
net, there is evidence that on some occasions it is the patient that 
both recommends the course of treatment and makes the final deci-
sumers comparative rankings of healthcare providers.  See, e.g., Top American Hospi-
tals—US News Best Hospitals, http://health.usnews.com/sections/health/best-
hospitals (last visited Mar. 20, 2009).  
 138 Stein, supra note 111. 
 139 The studies indicate that most physicians assent to patient demands.  See supra 
notes 97–109 and accompanying text.  Assent itself, however, is not necessarily wrong 
or dangerous.  Assent is only problematic when the physician fails to exercise his or 
her own medical judgment and subsequently provides the patient with medically 
contraindicated treatment.  This Article contends that only some of these physicians 
are violating their fiduciary duty when they provide assent—that is, those who are 
abdicating their responsibility to exercise sound medical judgment. 
 140 See Caroline L. Nadal, Note, The Societal Value of Prescription Drug Advertisements 
in the New Millennium:  Targeted Consumers Become the Learned, 9 J.L. & POL’Y 451, 504 
(2001) (“[P]atients often tell their physicians which prescription medication they 
wish to take, sometimes reducing physicians into mere purveyors of prescription 
slips.”). 
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sion.141  The doctor has potentially gone from being the sole decision-
maker, to being a joint decision-maker, to being an educated adviser 
and consultant, to being at most an inconvenient “speed bump” and 
at worst an irrelevant formality. 
The emergence of DTCA and the Internet has resulted in a fun-
damental change in the interactions between physicians and patients 
with patients playing a much more active role.142  The following ques-
tions must now be answered.  What role should physicians play in 
these interactions?  And what bounds are or should be placed on re-
lated physician behavior by medical ethics and governing law? 
V. THE DOCTOR’S OBLIGATIONS 
A. Informed Consent 
The term “informed consent” was coined and explained in Salgo 
v. Leland Stanford Jr. University Board of Trustees,143 where a California 
Court of Appeals declared that “[a] physician violates his duty to his 
patient and subjects himself to liability if he withholds any facts which 
are necessary to form the basis of an intelligent consent by the pa-
tient to the proposed treatment.”144  Within the next few decades, ob-
taining informed consent became an ethical and legal duty imposed 
on physicians throughout the country.145  The core ethics committee 
of the American Medial Association (AMA), the Judicial Council (re-
named the Council on Ethical and Judicial Affairs in 1985), an-
nounced the AMA’s stance on informed consent in 1982: 
The patient’s right of self-decision can be effectively exercised 
only if the patient possesses enough information to enable an in-
telligent choice.  The patient should make his own determination 
on treatment. . . .  Social policy does not accept the paternalistic 
 141 See, e.g., Perez v. Wyeth Labs., 734 A.2d 1245, 1260 (N.J. 1999) (“[Physicians] 
claim pushy patients, prodded by the DTC advertisements, pressed, wheedled, 
begged and berated them for quick treatments.”). 
 142 See, e.g., Calabro, supra note 83, at 2272 (“Direct-to-consumer advertising 
[places pressure on physicians] by changing the physician-patient relationship such 
that the physician may no longer be in a superior position to warn his patient about 
the risks associated with the drug.”). 
 143 317 P.2d 170 (Cal. Dist. Ct. App. 1957). 
 144 Id. at 181. 
 145 The American Hospital Association included the following statement regard-
ing informed consent in its Patient’s Bill of Rights: “The patient has the right to re-
ceive from his physician information necessary to give informed consent prior to the 
start of any procedure and/or treatment.”  AMERICAN HOSP. ASS’N, PATIENT’S BILL OF 
RIGHTS para. 3 (Feb. 6, 1973), reprinted in DIETER GIESEN, INTERNATIONAL MEDICAL 
MALPRACTICE LAW appx. IV (1988).  
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view that the physician may remain silent because divulgence 
might prompt the patient to forego needed therapy.  Rational, in-
formed patients should not be expected to act uniformly, even 
under similar circumstances, in agreeing to or refusing treat-
ment.146 
Informed consent, which started as a legal duty imposed by the 
courts, is now viewed as so integral to minimally adequate healthcare 
that it has been transformed into an obligation incumbent upon and 
universally accepted by physicians.147  Physicians now have an ethical 
and legal responsibility to inform patients of the potential material 
risks and benefits of any proposed treatment and any viable alterna-
tives to treatment before obtaining a patient’s consent to perform a 
medical procedure, with patients generally given the right to make 
the ultimate decisions regarding the commencement and course of 
their treatment for themselves.148  Physicians, nevertheless, are not 
absolved from responsibility or liability simply because a patient ex-
presses a certain treatment choice, particularly if the patient’s choice 
is inconsistent with the physician’s judgment of what constitutes ap-
propriate medical practice. 
B. Informed Consent Alone Is Inadequate in a World of 
DTCA/Internet 
Pursuant to the requirements of the informed consent doctrine, 
physicians generally describe various possible courses of action to 
their patients, with patients choosing from among the options pro-
vided but often acquiescing in the judgment of their physician re-
garding the best course of treatment.149  The emergence of DTCA 
and other information “aids” has created the potential for a funda-
mental shift in this process.  Now, after exposure to DTCA or con-
ducting research on the Internet, a patient is much more likely to re-
 146 FADEN ET AL., supra note 22, at 96. 
 147 Id. at 101. 
 148 Id. at 100. 
 149 Whitney et al., supra note 49, at 54.  Critics have argued that informed consent, 
as it was designed, rarely occurs because physicians exercise considerable control 
over the decision-making process, in part by shaping the information provided the 
patient and in part because the patient relies heavily on cues and direction provided 
by the physician.  They assert that beneficence still dominates the physician-patient 
relationship and that doctors continue to make virtually all of the treatment deci-
sions.  GEORGE ANNAS, SOME CHOICE: LAW, MEDICINE, AND THE MARKET 61, 66 (1998) 
(“[A]fter almost three decades of legal and ethical debate, neither the idea nor the 
ideal of informed consent governs the doctor-patient relationship. . . .  [While] in-
formed consent is well entrenched in theory . . . in practice patient autonomy con-
tinues to be elusive.”).  
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quest or perhaps demand a specific treatment option—including op-
tions that the physician did not or would not have raised and that the 
physician does not 
This potential shift in the nature of the interaction between the 
physician and the patient necessitates a corresponding recognition 
that merely informing patients of their treatment options does not 
mark the end of physicians’ responsibility to their patients.150  Even at 
its apex—when it afforded the greatest weight to patient autonomy—
the informed consent doctrine only required a physician to provide a 
patient with material information regarding the various alternative 
treatment options available before the patient “consented” to a given 
course of treatment.151  It did not establish that the physician must in-
evitably acquiesce to whatever course of treatment the patient desires. 
As discussed, before the advent of DTCA and the Internet, the 
question of who exercises ultimate decision-making authority in a 
physician-patient relationship would largely have been irrelevant, as 
patients rarely knew enough to independently generate and appraise 
treatment options, and physicians would have been unlikely to raise 
treatment options that they did not think were viable or were unwill-
ing to perform.  Indeed, physicians generally are not required in the 
course of obtaining informed consent to raise treatment options that 
contain significant risks but lack corresponding benefits.  In essence, 
because physicians only introduced what they considered to be viable 
treatment options, physicians exercised their independent medical 
judgment, provided their “implied consent” to the discussed options, 
and maintained their critical role in medical decision making.152 
This critical role, however, is not fulfilled when the patient re-
quests and the physician acquiesces in a treatment that the physician 
believes is medically contraindicated.  As will be discussed, physicians 
cannot satisfy their ethical and legal obligation to their patients sim-
ply by providing all material information regarding the options dis-
cussed.  When a physician acquiesces to a patient’s request for treat-
ment that the physician believes is medically contraindicated, the 
 150 As will be discussed, this Article asserts that this more stringent duty already ex-
ists in the form of the physician’s fiduciary duty.  See infra Part VI. 
 151 See Rich, supra note 56, at 102 (outlining the requirements of informed con-
sent). 
 152 Because of fewer financial pressures, physicians also may have felt freer to re-
ject a course of treatment requested by a patient and, if the patient insisted on this 
course of treatment, to terminate the physician-patient relationship. 
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physician has failed to fulfill his or her fiduciary obligation as a 
healthcare provider.153 
Before addressing the rationale for and the nature of this fiduci-
ary obligation, it is worth emphasizing that the focus here is the sce-
nario where the physician provides access to requested services that 
the physician believes are medically contraindicated.  The existing in-
formed consent doctrine adequately addresses situations where a pa-
tient proposes a viable medical alternative.  For example, if a patient 
who suffers from high cholesterol enters a doctor’s office and re-
quests the prescription medication Lipitor after viewing commercials 
touting its effectiveness, and it is the physician’s medical judgment 
that the patient is a good candidate for the drug—even though the 
doctor might prefer that the patient first attempt to lower his or her 
cholesterol through diet and exercise—the doctor has satisfied the 
requirements of the informed consent doctrine, as well as the physi-
cian’s fiduciary obligation to the patient, by explaining the material 
risks and benefits of these alternative options and then respecting the 
patient’s choice between two medically viable options.  That is, the 
physician should explain the relative advantages of exercise and 
healthy eating as opposed to using this medication, but the physician 
is free to acquiesce and order the patient’s requested treatment as 
long as (1) the physician has exercised his or her independent medi-
cal judgment and believes the drug is reasonably likely to be effective, 
and (2) the patient’s medical history or other factors do not make the 
ordering of this drug medically contraindicated. 
If, however, the treatment being sought is not medically indi-
cated in the physician’s judgment, the doctor has, as will be dis-
cussed, an ethical and a legal duty to refuse to comply with the pa-
tient’s request.  The doctor, not the patient, has the education and 
training necessary to determine when treatment is medically contra-
indicated under such a scenario and, thus, the responsibility to refuse 
 153 See supra Part V.A.  This may give rise to a cause of action based on medical 
malpractice or lack of informed consent.  These causes of action, however, are ill-
equipped to handle the given situation for a variety of reasons.   See Thomas L. 
Hafemeister & Selina Spinos, A Physician’s Fiduciary Duty to Disclose Emergent Medical 
Risk, 86 WASH. U. L. REV. (forthcoming June 2009) (manuscript at 38–44, on file with 
authors); see also Caroline Anne Forell & Anna Sortun, The Tort of Betrayal of Trust, U. 
MICH. J.L. REFORM (forthcoming 2009) (manuscript at 14–16), available at http:// 
papers.ssrn.com/sol3/papers.cfm?abstract_id=1112073#.  Here, informed consent is 
insufficient because the patient herself is seeking the treatment and thus providing 
consent, while medical malpractice is insufficient due to its focus on the standard of 
care, rather than the standard of conduct.  See infra Part VI.C.2. 
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to provide access to a treatment simply because it was requested or 
demanded by a patient.154 
C. Professional Judgment 
The doctor should not be a passive participant in medical deci-
sion making and become a mere formality needed to finalize the ex-
change between a pharmaceutical company and the target of its tele-
vision advertising or Internet promotions.  Physicians are well-
educated, well-trained professionals who are and should be responsi-
ble for determining whether a requested course of treatment is medi-
cally appropriate.  Whether they are administering prescription 
medications, performing surgical procedures, or providing or facili-
tating the delivery of other medical services and products, physicians 
must be ultimately responsible for treatment.  They must appraise 
whether a requested treatment is medically indicated for a given pa-
tient. 
As demonstrated by federal laws that limit access to controlled 
substances155 and state licensing requirements that limit who may pre-
scribe medications,156 society has made a collective decision not to al-
low the general public to gain unfettered access to many medications 
and other forms of medical treatment.  For example, an individual 
cannot simply walk into a pharmacy and obtain a regulated medica-
tion; rather, the patient must give the pharmacist a prescription 
signed by a physician.  This signed prescription indicates to the 
pharmacist that a licensed physician has consulted with the patient, 
performed any necessary tests and obtained any needed information, 
and determined that the patient should receive the prescribed medi-
cation.  This prescription process is designed to ensure that a li-
censed physician has determined that it is safe and appropriate for 
someone to take a certain drug.  Because physicians are charged by 
society with ensuring that medications and other forms of medical 
treatment are only made available when medically appropriate, phy-
sicians are obligated to exercise their professional judgment when 
providing treatment to their patients. 
Society’s decision to prevent broad, unfettered access to medica-
tions and other forms of medical treatment by the public has received 
ample support from the courts.  For example, in Reyes v. Wyeth Labora-
 154 Edwin Leap, I’m the Doctor, Not You!, EMERGENCY MED. NEWS, May 2007, at 19. 
 155 See 21 U.S.C. § 829(a)–(c) (2006) (describing when and how controlled sub-
stances may be dispensed). 
 156 See, e.g., FLA. STAT. ANN. §  458.345 (West 2007); IOWA CODE ANN. § 147.107 
(West 2005); KAN. STAT. ANN. § 65-2837a (2007). 
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tories,157 the United States Court of Appeals for the Fifth Circuit held 
that a pharmaceutical company is not liable for injuries caused by the 
prescription medications it manufactures and advertises as long as a 
“learned intermediary”—a doctor—authorized and implicitly rec-
ommended the medication through a prescription.  The court ex-
plained that 
in the case of a prescription drug which is unavoidably un-
safe, and as to which there is a certain, though small, risk 
throughout the population, there must be either a warn-
ing—meaningful and complete so as to be understood by 
the recipient—or an individualized medical judgment that this 
treatment or medication is necessary and desirable for this 
patient.158 
The ruling in Reyes gave birth to the learned intermediary rule, under 
which the proposition was endorsed that physicians are the least cost 
avoider—that is, doctors are in a better position to prevent adverse 
drug effects from contraindicated prescription medication than the 
pharmaceutical industry or the patient.  The learned intermediary 
rule demonstrates that society desires and needs a qualified gate-
keeper—the physician—to shoulder the responsibility of ensuring 
that various medical treatments, particularly prescription medica-
tions, are ordered and consumed only when medically indicated. 
Despite society’s recent emphasis on respecting and promoting 
patient autonomy, doctors must continue to play a significant role in 
ensuring that appropriate decisions are made regarding medical 
treatment.  Patients may have become “‘consumers’ . . . with . . . [a] 
right . . . to be actively involved in decision-making about treat-
ment,”159 but being involved in and unilaterally making a medical de-
cision are two very different scenarios. 
The physician must remain a knowledgeable and trained expert 
who exercises independent professional judgment before ordering or 
performing an agreed-upon treatment.  The physician is not a sub-
servient pawn in the patient’s life, but an erudite and trustworthy 
partner dedicated to promoting and protecting a patient’s medical 
well-being. 
 157 498 F.2d 1264 (5th Cir. 1974). 
 158 Id. at 1295 (emphasis added). 
 159 Mead & Bower, supra note 54, at 1090. 
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VI. THE PHYSICIAN’S OBLIGATION TO EXERCISE  
INDEPENDENT PROFESSIONAL JUDGMENT160 
A physician’s failure to exercise independent professional judg-
ment by ordering treatment that is not medically indicated but is de-
manded by a patient brings into play an often overlooked and argua-
bly underdeveloped doctrine—a physician’s fiduciary obligation to a 
patient.161  This section will address (1) the nature of fiduciary duties 
in general; (2) why a physician should be considered a fiduciary in 
general and with regard to medically contraindicated demands by a 
patient; (3) what is entailed by a cause of action for breach of a physi-
cian’s fiduciary duty to exercise independent medical judgment; and 
(4) the impact of the cause of action for breach of fiduciary duty. 
A. Fiduciary Duties: Development and Focus in General 
The doctrine of fiduciary duty has “deep roots” in the common 
law.162  This doctrine was originally developed to help govern the ad-
 160 See generally Thomas L. Hafemeister & Sarah Payne Bryan, Beware Those Bearing 
Gifts: Physicians’ Fiduciary Duty to Avoid Pharmaceutical Marketing, 57 U. KAN. L. REV. 
491, 519–28 (2009) (providing general overview and discussion of a physician’s fidu-
ciary duty to a patient); Hafemeister & Spinos, supra note 153 (manuscript at 24–33) 
(providing general overview and discussion of a physician’s fiduciary duty to a pa-
tient); Charity Scott, Doctors as Advocates, Lawyers as Healers, 29 HAMLINE J. PUB. L. & 
POL’Y 331, 337 (2008) (“This concept of the physician as fiduciary has become well 
accepted in both U.S. law and the ethical tenets of American professional medical as-
sociations.”). 
 161 See generally Tamar Frankel, Fiduciary Law, 71 CAL. L. REV. 795, 796 (1983) (“Lit-
tle has been written about the origin of fiduciary law, the rationales behind the crea-
tion of fiduciary duties, the remedies for violations of these duties, and the methods 
by which courts fashion such remedies.”). 
 162 Hafemeister & Bryan, supra note 160, at 519–20 (“Originally, fiduciary doctrine 
was the courts’ response ‘to the absence of a remedy . . . for beneficiaries injured by 
the disloyalty of [their] trustees.’  Over time, this doctrine has been extended beyond 
the trustee-beneficiary relationship to other relationships in which a party (the fidu-
ciary) is entrusted with the responsibility to act and make decisions on behalf of an-
other individual (the beneficiary), with the expectation that the fiduciary will seek to 
promote the beneficiary’s welfare.  Fiduciary relationships have been found to exist 
between partners of a company, directors and companies, attorneys and clients, 
agents and principals, stockbrokers and clients, and, directly relevant to this discus-
sion, physicians and patients.”) (citations omitted); Hafemeister & Spinos, supra note 
153 (manuscript at 25) (“Fiduciary duties have deep roots in the common law.  
Within the law governing the administration of trusts—where a trustee has been ap-
pointed to administer a corpus or an estate on behalf of a beneficiary—courts devel-
oped the concept of fiduciary duty.  Originally an equitable remedy to correct the 
harm done by a disloyal trustee, fiduciary duties now apply to many relationships in 
which a party is entrusted with the welfare of someone who is relatively vulnerable.”) 
(citations omitted). 
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ministration of trusts,163 with the goal of remedying harm caused by a 
disloyal trustee.164  The doctrine was later expanded to include other 
agency relationships.165  It now encompasses a range of relationships 
where one party (the fiduciary) is “entrusted with the welfare of 
someone [i.e., the beneficiary] who is relatively vulnerable,” includ-
ing transactions between attorneys and clients, guardians and wards, 
financial advisors and clients, and corporate officers and sharehold-
ers.166 
Currently, a fiduciary duty is generally construed to be “[a] duty 
of utmost good faith, trust, confidence, and candor owed by a fiduci-
ary . . . to the beneficiary; a duty to act with the highest degree of 
honesty and loyalty toward another person and in the best interests of 
the other person.”167  Additionally, a fiduciary must “promote the in-
terests of [the] beneficiar[y] rather than [the fiduciary’s] own inter-
ests.”168 
As noted, fiduciary obligations have been imposed on various 
professionals,169 and generally stem from (1) the beneficiary’s vulner-
ability and dependence on the fiduciary, (2) the superior knowledge 
and related skills of the fiduciary, and (3) the trust placed in the fi-
duciary to protect and promote the best interests of the beneficiary.170 
 163 Andrew Grubb, The Doctor as Fiduciary, 47 CURRENT LEGAL PROBS. 311, 311 
(1994). 
 164 Hafemeister & Bryan, supra note 160, at 519; Hafemeister & Spinos, supra note 
153 (manuscript at 25). 
 165 E. Haavi Morreim, The Clinical Investigator as Fiduciary: Discarding a Misguided 
Idea, 33 J.L. MED. & ETHICS 586, 588–89 (2005); Hafemeister & Bryan, supra note 160, 
at 519–20; Hafemeister & Spinos, supra note 153 (manuscript at 25). 
 166 Hafemeister & Bryan, supra note 160, at 519–20; Hafemeister & Spinos, supra 
note 153 (manuscript at 25); Morreim, supra note 165, at 588–89. 
 167 BLACK’S LAW DICTIONARY (8th ed. 2004). 
 168 Sharona Hoffman & Jessica Wilen Berg, The Suitability of IRB Liability, 67 U. 
PITT. L. REV. 365, 393 (2005). 
 169 See supra note 166 and accompanying text.  See also Frankel, supra note 161, at 
795 (“Fiduciaries appear in a variety of forms, including agents, partners, directors 
and officers, trustees, executors and administrators, receivers, bailees, and guardi-
ans.”); Hafemeister & Bryan, supra note 160, at 519–20; Hafemeister & Spinos, supra 
note 153 (manuscript at 25). 
 170 Frankel, supra note 161, at 796; Hafemeister & Bryan, supra note 160, at 520 
(“Fiduciary rules are designed to ensure that the fiduciary fulfills his or her obliga-
tions and does not neglect, abuse, exploit, or otherwise take advantage of the rela-
tively vulnerable and dependent beneficiary.”); id. at 524 (Fiduciary duties exist “be-
cause of the dependence and vulnerability of the beneficiary and the level of trust 
imbued in the fiduciary.”); id. at 526 (“The fiduciary duty doctrine was applied to 
trustees to control three aspects of the typical trustee-beneficiary relationship: the 
disparity of knowledge between the trustee and the beneficiary, the trustee’s ability 
to act relatively unilaterally, and the vulnerability and dependence of the beneficiary 
on the trustee.”). 
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B. Physicians as Fiduciaries 
1. Physicians’ Fiduciary Obligation to Their Patients 
In 1956, a California Court of Appeals declared that “[t]he doc-
tor-patient relationship is a fiduciary one.”171  Many courts over the 
years have determined that physicians owe a fiduciary obligation to 
their patients,172 stemming from the intrinsic nature of the physician-
patient relationship. 
The physician-patient relationship embodies all three bases rou-
tinely cited as the rationale for concluding that a fiduciary duty exists 
between two parties.  As the following discussion demonstrates, physi-
 171 Wohlgemuth v. Meyer, 293 P.2d 816, 820 (Cal. Ct. App. 1956) (“[I]t is incum-
bent on the doctor to reveal all pertinent information to his patient.”).  The recogni-
tion of a fiduciary relationship between physicians and patients can be further traced 
back to at least 1931 when the Minnesota Supreme Court specifically noted that a fi-
duciary relationship exists between physicians and patients.  Schmucking v. Mayo, 
235 N.W. 633, 633 (Minn. 1931).  In support of this proposition, the court cited Gro-
endal—a ruling from 1912 by the Michigan Supreme Court.  Groendal v. Westrate, 
137 N.W. 87, 96 (Mich. 1912) (“[T]he relation of physician and patient, which, of it-
self, begets confidence and reliance on the part of the patient.”). 
 172 See, e.g., Lambert v. Park, 597 F.2d 236, 239 n.7 (10th Cir. 1979) (“The duty of 
the doctor to inform the patient is in the nature of a fiduciary duty.”); Canterbury v. 
Spence, 464 F.2d 772, 782 (D.C. Cir. 1972) (“[W]e ourselves have found in the ‘fidu-
cial qualities of [the physician-patient] relationship the physician’s duty to reveal to 
the patient that which in his best interests it is important that he should know.’”) (ci-
tations omitted); Salis v. United States, 522 F. Supp. 989, 997 n.10 (M.D. Pa. 1981) 
(finding that the doctrine of informed consent is based partially on the fiduciary re-
lationship between physician and patient); Hammonds v. Aetna Cas. & Sur. Co., 237 
F. Supp. 96, 102 (N.D. Ohio 1965) (“It is axiomatic that the physician-patient rela-
tionship is a fiduciary one.”); Mull v. String, 448 So. 2d 952, 953 (Ala. 1984) (“Ala-
bama recognizes [a] cause[] of action for breach of fiduciary duty . . . resulting from 
a physician's unauthorized disclosure of information acquired during the physician-
patient relationship.”); Cobbs v. Grant, 502 P.2d 1, 12 (Cal. 1972) (“Any defense . . . 
must be consistent with . . . the ‘fiducial’ qualities of the physician-patient relation-
ship.”) (citation omitted); Berkey v. Anderson, 1 Cal. App. 3d 790, 804 (Cal. Ct. App. 
1969) (“The relationship between a physician and his patient is fiduciary, which, like 
all such relationships, imposes a duty of full disclosure.”); Wohlgemuth, 293 P.2d at 
820 (“The doctor-patient relationship is a fiduciary one . . . .”); Petrillo v. Syntex 
Laboratories, 499 N.E.2d 952, 960–61 (Ill. App. Ct. 1986) (“The fiducial nature of 
the physician-patient relationship flows not from the physician’s ethical duties, but 
rather as a result of the physician’s unique role in society.  Like the confidentiality of 
the physician-patient relationship, we believe that our society has an established and 
beneficial interest in the fiduciary quality of the physician-patient relationship.”); 
Woolley v. Henderson, 418 A.2d 1123, 1128 n.3 (Me. 1980) (“The historical under-
pinnings of the doctrine of informed consent are frequently attributed to the fiduci-
ary character of the physician-patient relationship.”); Borderlon v. Peck, 661 S.W.2d 
907, 908 (Tex. 1983) (“[T]he physician-patient relationship is one of trust and con-
fidence . . . .”); Nixdorf v. Hicken, 612 P.2d 348, 354 (Utah 1980) (noting the “fidu-
ciary nature of the physician-patient relationship”).  See also Hafemeister & Bryan, su-
pra note 160, at 527; Hafemeister & Spinos, supra note 153 (manuscript at 26). 
HAFEMEISTER (FINAL) 4/6/2009  10:45:41 PM 
370 SETON HALL LAW REVIEW [Vol. 39:335 
 
cians owe their patients a fiduciary obligation due to (1) the vulner-
ability of patients and their dependence on physicians for their medi-
cal care, (2) the considerable and superior knowledge and related 
skills of physicians, and (3) the trust that patients and society imbue 
in physicians to protect and promote their patients’ best interests.173 
a. Vulnerability and Dependence on the Physician 
The features of a physician-patient relationship closely resemble 
those of the typical fiduciary relationship.174  For example, physicians 
control access to and the use of important resources that patients 
need.175  Just as a trustee controls those funds and other assets desig-
nated to help the specified beneficiary of an established trust,176 the 
physician controls a patient’s ability to obtain needed resources to 
which the patient is otherwise entitled—namely, medical services, 
such as diagnostic tests and treatment, prescriptions for medications, 
admission to a hospital on a non-emergency basis, and referrals to a 
specialist, as well as third party payments for healthcare costs.177  Just 
as a trustee must protect the resources dedicated to the welfare of the 
beneficiary, a physician must promote and protect the health of pa-
tients, who have entrusted physicians with their safety and well-
being.178  Simply put, patients cannot access medical services pivotal 
to their health and survival without the aid of a physician.  This de-
pendence is enhanced by the fact that patients tend to contact physi-
cians when they are ill or suffering and in great need of the services 
to which only the physician can provide access.179  This vulnerability 
 173 Marc. A. Rodwin, Strains in the Fiduciary Metaphor: Divided Physician Loyalties and 
Obligations in a Changing Health Care System, 21 AM. J.L. & MED. 241, 245–46 (1995). 
 174 Id. at 245. 
 175 Id. 
 176 RESTATEMENT (SECOND) OF TRUSTS § 2 cmt. h (1959) (“[A] trust involves three 
elements, namely, (1) a trustee, who holds the trust property and is subject to equi-
table duties to deal with it for the benefit of another; (2) a beneficiary, to whom the 
trustee owes equitable duties to deal with the trust property for his benefit; (3) trust 
property, which is held by the trustee for the beneficiary.”). 
 177 Id. 
 178 See Maxwell J. Mehlman, Fiduciary Contracting Limitations on Bargaining Between 
Patients and Health Care Providers, 51 U. PITT. L. REV. 365, 389 n.76 (1990) (“Since pro-
viders often act for patients in situations wherein patients are unable to act for them-
selves, the fiduciary obligation might be said to arise in part because of the patient’s 
delegation of control, similar to the control delegated . . . by a beneficiary to a trus-
tee.”). 
 179 Hafemeister & Spinos, supra note 153 (manuscript at 26) (“Because patients 
generally seek the services of a physician when they are sick, injured, or concerned 
about their health, because doctors have unique access to a patient’s medical infor-
mation and superior insight into a patient’s medical condition, and because physi-
HAFEMEISTER (FINAL) 4/6/2009  10:45:41 PM 
2009] PHYSICIAN’S FIDUCIARY OBLIGATION TO SAY NO 371 
 
and dependence creates a significant need for the physician’s supe-
rior knowledge and related specialized skills.180 
b. Information and Skill Disparity 
In addition, the physician-patient relationship “must be subject 
to fiduciary requirements because of the information disparity be-
tween the parties.”181  While it is true that laypersons today have 
greater access to medical information than ever before (through the 
Internet, television, books, magazines, and so forth), such resources 
cannot compete with four years of medical school, completion of a 
residency, internships and fellowships, and years of firsthand experi-
ence.  In addition, physicians are required to obtain and maintain a 
license to practice medicine, which includes meeting educational re-
quirements, passing standardized exams, and satisfying continuing 
education requirements.182 
This knowledge discrepancy between physicians and patients is 
only exacerbated—not alleviated—by the misinformation and mis-
understanding that may result from DTCA and from unfettered ac-
cess to Internet-based medical information.183  The essential point is 
that the medical knowledge of a patient who has spent time on 
WebMD.com, or who has viewed an emotionally evocative commer-
cial does not remotely compare to that of a well-educated physician.  
While patients focused on their own symptoms and conditions can 
perform useful related research, gain relevant insights, and convey 
germane information to their physician, patients are rarely equipped 
to independently understand or apply this information, nor do they 
have the diagnostic and treatment skills needed to adequately and 
appropriately respond to this information.  Patients’ relative lack of 
medical knowledge and skills, as well as their vulnerability and de-
cians control patients’ ability to obtain needed medical treatment, patients are highly 
dependent on their physicians and should be able to rely on their physicians to pro-
tect and promote their well-being.” (citing Washington v. Glucksberg, 521 U.S. 702, 
731 (1997) (noting that “trust . . . is essential to the doctor-patient relationship”))).  
Patients generally do have the option of contacting a different physician to gain ac-
cess to needed services, but pursuing this option, with its delay and potential addi-
tional cost or disruption of an existing physician-patient relationship or delivery of 
services, can be highly burdensome for a patient—particularly if the patient is cur-
rently sick or injured. 
 180 Id. 
 181 Mehlman, supra note 178, at 366 n.6; see also Rodwin, supra note 173, at 245 
(explaining that physicians are similar to other fiduciaries because they “have special-
ized knowledge and expertise”). 
 182 See 1 BARRY R. FURROW ET AL., HEALTH LAW 62–63 (2000). 
 183 See supra Parts III & IV. 
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pendence on physicians, necessitate a relationship with their physi-
cian that is imbued with loyalty and trust.  This expectation of trust 
forms the foundation of the physician’s fiduciary obligations to a pa-
tient.184 
c. Patients’ Trust in Their Physicians 
In Cobbs v. Grant,185 the California Supreme Court recognized 
that “the patient, being unlearned in medical sciences, has an abject 
dependence upon and trust in his [or her] physician for the informa-
tion upon which [the patient] relies during the decisional process, 
thus raising an obligation in the physician that transcends arms-
length transactions.”186  Practically speaking, few professional rela-
tionships, if any, require more trust than a patient’s relationship with 
a physician.  Patients, for example, rely on their physicians’ advice in 
determining whether to undergo an invasive procedure or ingest po-
tent medications that may have significant risks, including possible 
adverse side effects.  In making these decisions, patients—and society 
in general—must be able to trust physicians, rely on their loyalty, and 
rest assured that physicians will place the patient’s best interests 
above all other potentially competing interests.187 
As in California, an Illinois Court of Appeals similarly deter-
mined that patients place a “special confidence” in their physicians 
when they seek medical assistance and that physicians, in turn, owe 
their patients a duty of “good faith” consistent with their fiduciary ob-
ligations.188  The court contended that “[t]he patient should . . . be 
able to trust [that] the physician will act in the [patient’s] best inter-
ests[,] thereby protecting the sanctity of the physician-patient rela-
tionship.”189 
The AMA itself has recognized that the physician-patient rela-
tionship is “based on trust” and thus physicians have an obligation to 
“place patients’ welfare above their own self-interest.”190  Due to the 
 184 Rodwin, supra note 173, at 245–46 (“The patient-physician relationship pre-
supposes patients entrusting physicians to act on their behalf and physicians remain-
ing loyal to their patients.”); see also infra notes 189–94 and accompanying text. 
 185 502 P.2d 1 (Cal. 1972). 
 186 Id. at 9. 
 187 Hafemeister & Bryan, supra note 160, at 530 (“[T]he purpose behind recogniz-
ing a breach of fiduciary duty claim in this context is to deter disloyal conduct on the 
part of the physician.”). 
 188 Taber v. Riordan, 403 N.E.2d 1349, 1353 (Ill. App. Ct. 1980). 
 189 Id. 
 190 AM. MED. ASS’N, CODE OF MEDICAL ETHICS, OPINION 10.015: THE PATIENT-
PHYSICIAN RELATIONSHIP (2001) [hereinafter AMA PATIENT-PHYSICIAN RELATIONSHIP], 
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level of trust that patients must be able to place in their physician, pa-
tients’ vulnerability to and dependence on physicians, and the dispar-
ity in information and skills that exists between patients and physi-
cians, physicians have a fiduciary obligation to protect the best 
interests of their patients.191 
2. A Physician’s Fiduciary Obligation to Refuse to Provide 
Treatment That Is Not Medically Indicated 
The AMA has stated that “[p]hysicians are not ethically obliged 
to deliver care that, in their best professional judgment, will not have 
a reasonable chance of benefiting their patients[,]  [and p]atients 
should not be given treatments simply because they demand them.”192  
Because the AMA generally recognizes that physicians have an ethical 
duty to exercise independent medical judgment,193 the question be-
comes whether a doctor’s fiduciary obligation legally requires the doc-
tor to “just say no” to a demanding patient. 
As indicated previously, a fiduciary is required to promote the 
interests of the beneficiary rather than the fiduciary’s own interests.194  
available at http://www.ama-assn.org/ama1/pub/upload/mm/Code_of_Med_Eth/ 
opinion/opinion10015.html. 
 191 See Taber, 403 N.E.2d at 1353 (“There can be little dispute that a doctor occu-
pies a condition of trust and confidence, a fiduciary relationship with his [or her] pa-
tient.”) (citation omitted). 
 192 AM. MED. ASS’N, CODE OF MEDICAL ETHICS, OPINION 2.035: FUTILE CARE (1994), 
available at http://www.ama-assn.org/ama1/pub/upload/mm/Code_of_Med_Eth/ 
opinion/opinion2035.html.  This statement by the AMA relates to the delivery of fu-
tile care, but it is just as applicable, if not more so, in the case of DTCA.  Generally 
speaking, futile care involves treatment that is unnecessary or wasteful, but not harm-
ful.  In contrast, DTCA may involve treatment that is not only unnecessary or waste-
ful, but also potentially harmful—or at least may involve drugs or procedures that in-
volve unnecessary risks. 
 193 See AM. MED. ASS’N, PRINCIPLES OF MEDICAL ETHICS (2001), available at http:// 
www.ama-assn.org/ama/pub/category/2512.html (“As a member of this profession, 
a physician must recognize responsibility to patients first and foremost . . . .  A physi-
cian shall be dedicated to providing competent medical care . . . .  A physician shall, 
while caring for a patient, regard responsibility to the patient as paramount.”); AM. 
MED. ASS’N, CODE OF MEDICAL ETHICS, OPINION 8.03: CONFLICTS OF INTEREST: 
GUIDELINES (1994), available at http://www.ama-assn.org/ama1/pub/upload/mm/ 
Code_of_Med_Eth/opinion/opinion803.html (“Under no circumstances may physi-
cians place their own financial interests above the welfare of their patients. . . . If a 
conflict develops between the physician’s financial interest and the physician’s re-
sponsibilities to the patient, the conflict must be resolved to the patient’s benefit.”); 
William J. Plested III, President, Am. Med. Ass’n, A Declaration of Independence 
(June 23, 2007), available at http://www.ama-assn.org/ama/pub/category/17781. 
html (“The time has come for the Physicians of America . . . to issue our own Decla-
ration of the Independence, the independence of our profession.”). 
 194 Supra note 168 and accompanying text. 
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As fiduciaries, physicians must “hold[] the best interests of the pa-
tient . . . paramount,” even when they may face adverse financial con-
sequences as a result.195  As described in the scenario at the beginning 
of this Article, physicians may, for example, have a financial interest 
in keeping their patients happy—that is, they may find it in their self-
interest to give their “consumers” what they want in the way of medi-
cal services to ensure that they will receive their patients’ future busi-
ness.196  Because of patients’ limited ability to make medical decisions 
for themselves, however, physicians—to properly serve the best inter-
ests of their patients—must always exercise their independent medi-
cal judgment and provide access only to appropriate medical services. 
Thus, to satisfy their fiduciary obligation, physicians should au-
thorize access only to those services that reflect and represent the ex-
ercise of their independent medical judgment and that are medically 
indicated for the patient—that is, provide access consistent with the 
patient’s medical needs and condition.  To ensure that physicians re-
tain their valued and valuable role in the physician-patient relation-
ship, physicians must always exercise their independent medical 
judgment, even when doing so is contrary to the expressed wishes of 
the patient and may jeopardize the physician’s financial well-being or 
other self-interests.  If physicians fail to exercise their medical judg-
ment, they violate their fiduciary obligation to the patient and should 
be subject to potential legal liability. 
C. What Is Entailed by a Cause of Action for Breach of a Physician’s 
Fiduciary Duty to Exercise Independent Medical Judgment 
Physicians who do not exercise independent medical judgment 
in the face of a specific request from a patient for treatment that is 
medically contraindicated fail to meet their fiduciary obligation to 
that patient.  Physicians who fail to meet this obligation may be sub-
ject to a cause of action for breach of their fiduciary obligation. 
 195 AMA PATIENT-PHYSICIAN RELATIONSHIP, supra note 190. 
 196 As interest increases in making “consumer” ratings publically available, the sat-
isfaction of a physician’s patients with the services provided may shape the willing-
ness of other prospective patients to utilize the physician’s services.  See generally Reed 
Abelson, National Standards to Rank Physicians Planned, N.Y. Times, Apr. 1, 2008, at 
C3; Could CMS Start ‘Physician Profiling’ in the Near Future? CONTEMP. OB/GYN, Aug. 1, 
2007. 
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1. Elements of a Claim for Breach of Fiduciary Duty 
A claim for breach of fiduciary duty generally sounds in tort.197  
As a result, to successfully pursue such a claim, generally four ele-
ments must be shown: (1) the existence of a fiduciary duty, (2) a 
breach of that duty, (3) damages (harm) incurred by the person to 
whom that duty was owed, and (4) a causal link between the breach 
and the resulting harm.198 
As established earlier, physicians owe their patients a fiduciary 
obligation in general.199  To satisfy the first element of a cause of ac-
tion for breach of fiduciary duty, a plaintiff has to show that a physi-
cian-patient relationship existed between the plaintiff and the defen-
dant at the time of the alleged misconduct, that the physician was 
acting within the scope of that relationship, and that the fiduciary 
duty in question is inherent in physician-patient relationships.  Also, 
the physician as a fiduciary is obligated, among other things,200 to ex-
ercise his or her independent medical judgment during the course of 
the physician-patient relationship, notwithstanding that the patient 
 197 It can be argued that a breach of fiduciary duty claim should sound in contract 
rather than in tort, or should reflect a combination of the two doctrinal foundations.  
For example, it can be contended that a breach of fiduciary duty claim constitutes a 
contractual violation because a fiduciary breach is a violation of the expectations of 
the two parties.  In addition, it might be noted that, historically, the fiduciary duty—
with its focus on trustees and the designated beneficiaries of a trust—was based in 
trust law, a third possible foundation for a cause of action focused on a breach of a 
physician’s fiduciary obligations.  An exploration of the strengths, weaknesses, and 
appropriateness of each of these alternative doctrinal approaches is beyond the 
scope of this Article.  Because the approach predominantly used currently is a tort 
claim, this Article will employ that approach in conjunction with the analysis pro-
vided here.  For a brief discussion of these alternative doctrinal foundations, see 
Hafemeister & Bryan, supra note 160, at 519 n.168). 
 198 1615 PLI CORP. LAW & PRACTICE HANDBOOK 521, 548 (2007); see also Gracey v. 
Eaker, 837 So. 2d 348, 353 (Fla. 2002) (“The elements of a claim for breach of fidu-
ciary duty are: the existence of a fiduciary duty, and the breach of that duty such that 
it is the proximate cause of the plaintiff's damages.”).  But see Hafemeister & Bryan, 
supra note 160, at 524 (“[M]any states do not have either a causation requirement or 
an actual harm requirement associated with their fiduciary causes of action.  This is 
in part because (1) the breach of loyalty is the harm and (2) the purpose behind 
recognizing breach of fiduciary duty claims is to remove the incentive for disloyal 
conduct on the part of the fiduciary by confiscating the profits gained by fiduciaries 
as a result of their conduct, not necessarily to restore beneficiaries to their position 
ex ante by compensating their losses.”) (citations omitted). 
 199 See supra Part VI.B.1. 
 200 For example, a physician may have a fiduciary duty to keep medical records 
and information received in the course of the physician-patient relationship confi-
dential and private, to not engage in a sexual relationship with a current patient, to 
avoid conflicts of interests that may compromise medical judgment, and to disclose 
to a patient adverse medical conditions of which the patient is unaware.  See Hafe-
meister & Bryan, supra note 160, at 527. 
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has made a specific request for, and in some cases demanded, a par-
ticular medical service. 
As for the second element, physicians breach their fiduciary duty 
to patients when they abdicate their responsibility to exercise inde-
pendent medical judgment and provide their patients with access to 
medical services that are not medically indicated.201  A breach of this 
duty occurs even though the patient has requested or demanded 
these services and the physician has disclosed to the patient the risks 
associated with these services.  A physician cannot abdicate this re-
sponsibility and permit the patient to assume the risk associated with 
a medical service that the physician, exercising independent medical 
judgment, believes is not medically indicated.202  A patient who 
strongly desires such a medical service is of course free to seek this 
service from some other physician who may conclude that it is medi-
cally indicated.203  But a physician who has failed to exercise inde-
pendent medical judgment in response to a request or demand from 
a patient for a specific medical service has breached the physician’s 
fiduciary obligation to that patient. 
The damages element in tort law generally requires that the 
plaintiff suffered actual harm as a result of the breach of duty.204  
 201 See supra Part VI.B.2. 
 202 Under this standard, because a placebo by definition is not expected to pose a 
risk to a patient, it could be argued that a physician who, unbeknownst to the pa-
tient, substitutes a placebo for a requested but medically contraindicated prescrip-
tion could thereby avoid a potential cause of action for breach of fiduciary duty.  The 
use of placebos in medical practice is not uncommon.  See Laura Blue, Is Your Doctor 
Prescribing Placebos? TIME, Jan. 3, 2008, http://www.time.com/time/health/article/ 
0,8599,1700079,00.html (last visited Mar. 20, 2009) (reporting that forty-five percent 
of responding physicians “said they had prescribed placebos in [their] regular clini-
cal practice and . . . just over half had prescribed a placebo in the previous year.  
Among the reasons the doctors gave: to calm a patient down, to respond to demands 
for medication that the doctor felt was unnecessary, or simply to do something after 
all other treatment options had failed.” (citing Rachel Sherman & John Hickner, 
Academic Physicians Use Placebos in Clinical Practice and Believe in the Mind–Body Connec-
tion, 23 J. GEN. INTERNAL MED. 7 (2008))).  However, prescribing a placebo without 
the patient’s knowledge may represent a breach of the physician’s duty to obtain in-
formed consent before administering treatment.  Id. 
 203 This physician, if independent medical judgment was exercised, would not be 
subject to a cause of action for a breach of fiduciary duty.  However, if the physician 
provided access to a medical service that was medically contraindicated, the physician 
may be subject to a cause of action for medical malpractice if damages to the patient 
result from this access.  See 1 FURROW ET AL., supra note 182, at 264 (“Malpractice is 
usually defined as unskillful practice resulting in injury to the patient, a failure to ex-
ercise the ‘required degree of care, skill and diligence’ under the circumstances.”). 
 204 DAN B. DOBBS, THE LAW OF TORTS 405 (2000) (“[D]amages are not presumed 
[in a claim based upon negligence] as they are in the case of some intentional torts; 
the plaintiff who is not harmed by negligence cannot even recover nominal damages.  
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However, unless specifically required within a given jurisdiction, the 
law governing causes of action for a breach of a fiduciary relationship 
may not require a plaintiff to show that the patient experienced ac-
tual harm.205  This variation “is in part because (1) the breach of loy-
alty is the harm and (2) the purpose behind recognizing breach of 
fiduciary duty claims is to remove the incentive for disloyal conduct 
on the part of the fiduciary[,] . . .  not necessarily to restore benefici-
aries to their position ex ante by compensating their losses.”206  The 
absence of actual harm may greatly diminish the award that is avail-
able,207 but a physician’s failure to exercise independent medical 
judgment could result in an award of nominal compensatory dam-
ages, with the possibility of an additional award of attorney’s fees or 
punitive damages.208  Although a breach of this fiduciary duty may not 
result in any physical harm to the patient, an award of damages may 
be appropriate in some cases to deter this type of breach. 
To prove causation, a possible fourth element of this cause of ac-
tion, the patient may have to show that “but for” the physician’s 
breach the resultant harm would not have occurred.209  Within the 
context of this Article, the question could become whether the harm 
to the patient would have occurred even if the physician had said 
“no” to the patient’s request or demand for a particular medical ser-
vice.  If a physician can demonstrate that the harm would have oc-
curred anyway (for example, that the patient would have had a myo-
cardial event even if he had not taken the medication), the physician 
More significantly, the statement means that the plaintiff must prove not merely that 
she suffered harm sometime after the defendant’s negligent act occurred but that 
the harm was caused in fact by the defendant’s conduct.”). 
 205 Hafemeister & Bryan, supra note 160, at 524. 
 206 Id.  
 207 There can, of course, be actual harm associated with a physician providing a 
patient with access to a contraindicated medical service (such as medication).  For 
example, building upon the hypothetical that opened this Article, it should be noted 
that the FDA has posted on its web site the results of studies that indicate that there is 
a small but measurable risk of a heart attack in individuals with high blood pressure 
who ingest certain drugs widely prescribed to increase sexual performance.  Press Re-
lease, U.S. Food and Drug Admin., Patient Information: CIALIS (See-AL-iss) (tadala-
fil) Tablets (2007), available at http://www.fda.gov/medwatch/safety/2007/Oct_PI/ 
Cialis_PPI.pdf.  Ordering contraindicated medical services can also expose a physi-
cian to a medical malpractice claim.  See infra Part VI.C.2. 
 208 See Hafemeister & Bryan, supra note 160, at 524–25. 
 209 1 FURROW ET AL., supra note 182, at 302 (“Tests [in medical malpractice claims] 
for causal connections between the plaintiff’s injury and the defendant’s negligence 
are usually described by the courts in terms of the ‘but for’ test.  ‘But for’ the defen-
dant’s conduct, the plaintiff would not have suffered injury.  The plaintiff must pre-
sent testimony that the defendant’s acts or omissions probably caused the plaintiff’s 
injuries.”). 
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might not be found liable.210  However, for the same reasons, as dis-
cussed above, that a showing of actual harm may not be required, in 
some jurisdictions a causation requirement may not be mandated for 
a breach of fiduciary duty claim.211 
2. A Fiduciary Duty as Opposed to a Medical Malpractice 
Cause of Action 
While the elements of a fiduciary duty claim can be very similar 
to the elements of the more frequently pursued medical malpractice 
claim (duty, breach of duty, causation, and damages), they are dis-
tinct causes of action.212 
The fundamental difference between a medical malpractice 
claim and a fiduciary duty claim is that the former reflects an asserted 
breach of the physician’s duty of care, while the latter focuses on a 
purported breach of the physician’s duty of conduct.213  Negligence 
doctrine, the foundation for a medical malpractice claim, seeks to 
enhance the quality of healthcare and to make physicians more pru-
dent in their delivery of medical services by holding them liable for a 
failure to exercise the degree of care, skill, and diligence of a compe-
tent physician under similar circumstances (i.e., to do what is cus-
tomary within the profession in a given context).214  In contrast, the 
recognition of a fiduciary duty indicates that certain conduct is unac-
ceptable even if the fiduciary can identify other fiduciaries who acted 
in a similar manner or articulate other possible justifications for the 
behavior.  Fiduciary doctrine does not seek to make physicians more 
 210 One of the drawbacks to relying on a tort approach, as seen here, is that it al-
lows the physician to avoid legal liability despite violating a fundamental expectation 
associated with the privilege of being a physician, namely, that a physician will exer-
cise independent medical judgment before authorizing medical services.  It is be-
yond the scope of this Article, but it is arguable that a lawsuit for breach of a fiduci-
ary duty should be a quasi-contractual action rather than a tort action to avoid 
impediments resulting from a required showing of actual harm resulting from the 
breach (that is, damages and causation). 
 211 See supra note 198 and accompanying text. 
 212 The similarities are such that at least one commentator has argued that the 
“breach of fiduciary duty” claim should be eliminated altogether when its functions 
are served by a professional malpractice claim.  See Charles W. Wolfram, A Cautionary 
Tale: Fiduciary Breach as Legal Malpractice, 34 HOFSTRA L. REV. 689, 690–92 (2006). 
 213 Id. at 691 (“[W]hile negligence is based on a claim of breach of a standard of 
care, fiduciary breach is properly based on a claim of breach of a standard of con-
duct . . . .”). 
 214 See 1 FURROW ET AL., supra note 182, at 264. 
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“careful,”215 but rather seeks to establish what is minimally necessary 
behavior and, conversely, what behavior will not be tolerated regard-
less of the circumstances.  Fiduciary doctrine establishes that there 
are some actions by a physician (as with any fiduciary) that are by 
consensus (within and outside the profession) so expected or repug-
nant that excuses (that is, legal defenses) for failing to act in the ex-
pected manner should not be available. 
Thus, when a patient has demanded medically contraindicated 
care, even though a medical malpractice claim may be untenable due 
to the defenses of assumption of risk or contributory or comparative 
negligence,216 such defenses should not be available as a response to a 
breach of fiduciary duty claim if the physician failed to exercise inde-
pendent medical judgment in responding to this demand.  A fiduci-
ary cause of action does not focus on “fault” (as in where due care 
was not exercised); rather, it addresses behaviors in which no physi-
cian should engage.  There are simply some things that a fiduciary 
cannot do.  When the fiduciary crosses that line, regardless of the ex-
planation given for that behavior or whether harm directly resulted 
from it (the sine qua non of a negligence cause of action), conse-
quences should flow, and a cause of action for breach of fiduciary 
duty should be available.217 
Another important difference between the two causes of action 
is the nature of the proof necessary for the plaintiff to prevail.218  Be-
cause medical malpractice involves a failure to exercise due care (that 
is, the level of care customarily expected of members of that profes-
sion under the circumstances), expert testimony is required to dem-
onstrate what the standard of care is and that a physician failed to 
meet that standard.219  An action for breach of fiduciary duty, how-
ever, does not require the patient to demonstrate that the physician 
failed to exercise due care.  Instead, the plaintiff need only show that 
the physician’s conduct violated basic rules of conduct regarding how 
 215 See, e.g., Ray Ryden Anderson & Walter W. Steele, Jr., Fiduciary Duty, Tort, and 
Contract: A Primer on the Legal Malpractice Puzzle, 47 SMU L. REV. 235, 249 (1994) 
(“[Fiduciary] duties may be violated without any showing of negligence.”). 
 216 See, e.g., Ostrowski v. Azzara, 545 A.2d 148, 151–53 (N.J. 1988); see also 1 
FURROW ET AL., supra note 182, at 294–97. 
 217 Anderson & Steele, supra note 215, at 249. 
 218 Id. at 254. 
 219 Id. 
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all physicians are expected to act, for which expert testimony may not 
be required.220 
D. The Impact of a Fiduciary Cause of Action Requiring Physicians to 
Exercise Independent Medical Judgment 
Expressly recognizing that physicians have an obligation to exer-
cise independent medical judgment when a patient asks them to au-
thorize access to services that are not medically indicated does not 
necessitate a change in existing substantive law.  Instead, it merely re-
quires an embracement and explication of the doctrine that physi-
cians owe a fiduciary duty to their patients.  The effect of recognizing 
a cause of action for failing to “just say no” to a patient should be to 
provide clearer guidance to medical practitioners and to encourage 
them to fulfill their responsibility to reject requests from patients for 
services that are not medically indicated.221 
Because of recent developments in the doctrine of informed 
consent, some physicians may believe that as long as the patient has 
been informed of the potential risk of the requested service and rea-
sonable alternatives, physicians have an obligation to permit patients 
to choose whatever course of medical services they desire.  The physi-
cian’s fiduciary duty, however, does not permit the physician to abdi-
cate his or her obligation to exercise independent medical judgment 
on behalf of a patient.  When the service requested by the patient is 
not medically indicated, the physician must refuse to authorize access 
to that service. 
VII. THE BENEFITS OF RECOGNIZING THAT PHYSICIANS  
HAVE A FIDUCIARY DUTY TO EXERCISE INDEPENDENT MEDICAL 
JUDGMENT IN RESPONSE TO A PATIENT’S DEMAND FOR A SERVICE  
THAT IS NOT MEDICALLY INDICATED 
Recognizing that doctors have a fiduciary duty to resist a pa-
tient’s demand for a service that is not medically indicated will be 
beneficial to the doctor, the patient, and society as a whole. 
 220 Id. (“[B]ecause an action based on breach of fiduciary duty raises the issue 
only of whether the [fiduciary]’s conduct violated rules governing the profession, an 
expert’s testimony is not required to show violation of those rules.”). 
 221 Recognizing a cause of action for breach of fiduciary duty in this instance can 
also empower physicians to speak when a contentious request for “futile” care is 
made.  See supra note 192 and accompanying text; see also COUNCIL ON ETHICAL AND 
JUDICIAL AFFAIRS, AM. MED. ASS’N, MEDICAL FUTILITY IN END-OF-LIFE CARE: REPORT OF 
THE COUNCIL ON ETHICAL AND JUDICIAL AFFAIRS, in 281 JAMA 937, 940 (1999) (argu-
ing for a “fair process approach” to resolve questions regarding futile medical care). 
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A. Benefits to Physicians 
Although it may seem counter-intuitive on its face, physicians 
will enjoy a distinct benefit as the result of recognizing physicians’ fi-
duciary duty to refuse to comply with a patient’s request for a service 
that is not medically indicated.  It will empower members of the pro-
fession to fully exercise their training and skills and will minimize fi-
nancial incentives that might otherwise lead them to diminish and 
perhaps even abdicate their role in medical decision making. 
Charging physicians with a responsibility to refuse requested 
treatment that is inconsistent with their medical judgment inherently 
gives them the right to refuse patient demands for medically contra-
indicated treatment.  Just as a patient has a general right to refuse 
treatment that a physician recommends, physicians have a general 
right to refuse to provide treatment on which a patient inappropri-
ately insists.222  As a result, both can be active participants in medical 
decision making—the doctor can reject a patient’s proposal if it does 
not represent “good” medicine, and the patient can reject a doctor’s 
proposal if it does not match what the patient believes is needed un-
der the circumstances.  This is likely to enhance the quality of and 
satisfaction with the medical care provided, while protecting and 
promoting the autonomy of both the patients and the physicians in-
volved in these decisions.  In sum, imposing liability on physicians for 
a failure to “say no” to a patient’s request or demand for treatment 
that is not medically indicated duly empowers physicians to decline to 
provide access to such treatment.223 
 222 See Rahul K. Parikh, Showing the Patient the Door, Permanently, N.Y. TIMES, June 
10, 2008, at F6 (asserting that the physician-patient compact “gives a doctor the right 
to dismiss a patient”).  It should be noted that this Article does not advocate that 
physicians return to an inherently dominant role in their relationships with pa-
tients.  Such a relationship is not therapeutic or “good” medicine.  This Article 
strongly support a collaborative relationship between physicians and patients where 
both have vital roles to play. 
 223 It should be emphasized that this power to “say no” to a patient’s request or 
demand for treatment only recognizes treatment refusals that are not medically indi-
cated (that is, those that do not reflect the medical interests of the patient).  It does 
not embrace refusals that are based on the physician’s personal preference, conven-
ience, or financial advantage.  Requiring a patient to seek services from an alterna-
tive healthcare provider can entail considerable inconvenience and risk for the pa-
tient.  A patient may not be able to find a healthcare provider readily available.  For 
example, there may be a limited pool of healthcare providers willing to provide ser-
vices to Medicare or Medicaid patients because of the deep discounts in payments for 
services afforded these patients.  See supra note 134 and accompanying text.  An al-
ternative healthcare provider may be located farther away or at a location that is dif-
ficult for the patient to access, which can cause considerable hardship for an ailing 
patient.  The patient must introduce the alternative healthcare provider to the na-
ture of his or her medical problem and provide relevant medical history, which may 
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During this era of DTCA and Internet access to medical infor-
mation, physicians may be concerned that they will lose patients criti-
cal to the physicians’ financial well-being if they refuse to provide re-
quested medication or access to other medical services.  Their 
concern may be justifiable.  One survey found that seventy-five per-
cent of polled patients said they would switch doctors to get the 
medicine they wanted.224  With a clear legal obligation to refuse re-
quests that are not medically indicated, physicians will be less likely to 
fear that they will experience financial disadvantage if they fail to ac-
quiesce to such patient requests.  Because every physician will now 
have a responsibility to refuse these requests, all physicians will be in 
the same financial position, and patients will not be able to “shop 
around” for a physician who is willing to disregard his or her fiduciary 
responsibility. 
B. Benefits to Patients 
A primary benefit to patients from recognizing a physician’s fi-
duciary duty to exercise independent medical judgment is that a 
check will be placed on imprudent, sometimes impulsive, and per-
haps even dangerous requests by patients.  Importantly, this check 
will be provided by an independent professional with the expertise 
and skill needed to appropriately review the request.  As discussed, 
patients, as lay persons with access to a growing, albeit frequently in-
complete or even misleading body of information that they may not 
adequately understand,225 are often not equipped to identify all of the 
risks and benefits of a possible course of medical action.  If their phy-
sicians abdicate their responsibility to independently review and de-
termine access to medical services, patients may be harmed by their 
requests or incur other losses needlessly, such as delayed access to 
more appropriate services or expenditures on costly but ineffective 
services.  Although the input of the patient should be encouraged 
and the patient’s choice regarding the course of treatment re-
spected,226 the patient’s interests will ultimately be promoted best if 
the physician is also an active participant in the medical decision 
making. 
delay the delivery of needed services.  Medical records must be transferred and vital 
information conveyed in the past that was not entered into those records may be lost.  
Medical “handoffs” in general tend to increase the risk of harm to patients.  See 
ROBERT M. WACHTER & KAVEH G. SHOJANIA, INTERNAL BLEEDING: THE TRUTH BEHIND 
AMERICA’S TERRIFYING EPIDEMIC OF MEDICAL MISTAKES 159–79 (2005). 
 224 Fushman, supra note 83, at 1172. 
 225 See supra notes 93–94 and accompanying text. 
 226 See supra notes 41–49 and accompanying text. 
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In addition, providing a cause of action to a patient whose physi-
cian has breached the fiduciary duty to exercise independent medical 
judgment will supply such patients with a legal remedy that can award 
compensation for this breach.  It might be argued that a physician’s 
failure to exercise independent medical judgment when providing 
access to services that are not medically indicated would be better 
addressed by approaching this as a breach of the physician’s ethical 
obligations.227  A physician’s violation of an ethical duty may result in 
reprimand by a board of licensure, suspension of the physician’s li-
cense to practice medicine, or even revocation of the right to practice 
medicine.228  However, these sanctions do not provide a remedy to 
the patient.  The patient will not be able to initiate or be directly in-
volved in related proceedings to ascertain whether the physician has 
breached his or her ethical obligation, and thus the patient will not 
receive the satisfaction that may result from being an active partici-
pant in these proceedings.  Also, the patient will only be compen-
sated for any harm incurred as the result of a breach of the physi-
cian’s fiduciary duty if the duty owed the patient is part of a 
recognized legal cause of action, as boards of licensure focus exclu-
sively on whether a reported wrongdoer should be sanctioned and do 
not provide an award of damages to individuals who have been 
harmed by the unethical actions of the licensed professional.229 
It might be argued that empowering physicians to reject patient 
requests for a desired course of treatment harms patients by dimin-
ishing their right to direct the course of their treatment.  However, 
the patient’s autonomy generally will not be compromised as a result.  
First, the physician cannot impose his or her preferred course of 
treatment on the patient but can only refuse to provide access to the 
services requested.  Second, a physician’s fiduciary obligation does 
not encompass a right to refuse requested services capriciously; 
 227 See generally Catherine T. Struve, Doctors, the Adversary System, and Procedural Re-
form in Medical Liability Litigation, 72 FORDHAM L. REV. 943, 972–75 (2004). 
 228 See generally 1 FURROW ET AL., supra note 182, at 75–76 (discussing physician li-
censure and disciplinary actions and their respective goals).  It is also worth noting 
that there is an ongoing debate over whether these sanctions are issued sufficiently 
frequently to deter inappropriate behavior by physicians.  Cf. Darren Grant & Kelly 
C. Alfred, Sanctions and Recidivism: An Evaluation of Physician Discipline by State Medical 
Boards, 32 J. HEALTH POL., POL’Y & L. 867 (2007) (evaluating data on sanction fre-
quency and repeat offenders).  There is little, if any, indication that such sanctions 
have been imposed on physicians for failing to exercise independent medical judg-
ment in the face of a patient’s request for services that are not medically indicated. 
 229 Comment, Professional Negligence, 121 U. PA. L. REV. 627, 683 (1973) (“The 
board [of licensure] has no power to order compensation to an injured party; in ef-
fect its power is limited to revocation of the license or lesser variants thereof.”). 
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treatment refusals are required only when the physician is seeking to 
protect and promote the patient’s best interests.  Third, if the patient 
disagrees with the physician’s refusal to order a requested medical 
service, the patient remains free to attempt to find a physician who 
believes the request is medically indicated. 
In general, as long as the requested course of treatment is medi-
cally indicated, the physician’s fiduciary obligation does not encour-
age a physician to reject the patient’s treatment request.  If a patient 
has a medically viable request, the recognition of this cause of action 
should not make it any more difficult for a patient to find a doctor 
who will honor the request.  The only time the patient will not re-
ceive requested access to services is when the request is not medically 
indicated.  Overall, patients are protected from harm but continue to 
be able to exercise adequate control over the medical decision mak-
ing germane to their well-being. 
Critics of this fiduciary cause of action may assert a “clean hands” 
argument, claiming that it is inappropriate to permit a patient to 
benefit from a lawsuit for actions by a physician when it was the pa-
tient who “compelled” the physician to breach his or her fiduciary ob-
ligation.  The law, however, requires that a physician be a gatekeeper 
for medical treatments, including prescription medications.230  It does 
not matter how hard someone knocks on the gate; the gatekeeper 
must only allow those through the gate who medically should enter.  
Simply put, a greater obligation is imposed on a highly educated, 
trained, and skilled licensed professional than on an uninformed pa-
tient.  Physicians should not be able to avoid liability for their actions 
simply because a patient “insisted” on a certain treatment.  By anal-
ogy, an automobile driver cannot defend a lawsuit against a passenger 
by stating that the passenger encouraged him to drive recklessly.  As a 
matter of law, the physician is and should be responsible for his or 
her medical decisions. 
 230 Every state has enacted laws that authorize licensed physicians to prescribe 
medications and generally exclude other individuals from doing so.  James L.J. 
Nuzzo, Independent Prescribing Authority of Advanced Practice Nurses: A Threat to the Public 
Health?, 53 FOOD & DRUG L.J. 35, 41 (1998) (“[P]hysicians . . . have enjoyed a phar-
maceutical prescription monopoly in fact since the early part of the century and in 
law since the [federal Food, Drug, and Cosmetic Act] was passed in 1938 . . . .”).  Fur-
ther enhancing physicians’ gate-keeping function, the Controlled Substances Act of 
1970 provides an exhaustive list of drugs that are available only by prescription.  Pub. 
L. No. 91-513, 84 Stat. 1236 (1970). 
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C. Benefits to Society 
Society has an interest in the protection of the health and well-
being of its members.231  As discussed, in the case of potentially dan-
gerous prescription medications, for example, gatekeepers are neces-
sary to ensure the safety of those seeking these drugs.232  Approxi-
mately 200,000 Americans die each year from adverse reactions to 
prescription medications.233  Furthermore, 2.2 million injuries occur 
annually as a result of adverse drug events.234  In fact, adverse drug 
reactions are responsible for an astounding five percent of all hospi-
tal visits in the United States.235  Society has a strong interest in pro-
tecting its members from and minimizing the occurrence of these ad-
verse events.  Because of their risk, medications and other medical 
services should only be prescribed when medically indicated.  Fur-
thermore, in light of continuing concerns regarding the escalating 
costs of healthcare,236 providing physicians with a legal incentive to 
refrain from providing patients with access to services that are not 
medically indicated may help to control these costs. 
Physicians are in a better position to protect individuals from po-
tentially harmful medications that are not medically indicated than 
the individuals themselves.  Physicians have the expertise and train-
ing to accurately diagnose the patient’s condition and to understand 
the relative risks and benefits of the courses of treatment being con-
sidered.  Placing a legal duty on physicians to utilize their knowledge 
to protect the health and safety of their patients provides a benefit to 
all of society. 
In the scenario addressed by this Article, there is an inevitable 
tension present.  Society must weigh the potential diminishment of 
the autonomy of the patient (that is, the patient’s right to exercise 
complete control over the medical decision making relevant to that 
patient’s body) against the need to ensure appropriate medical deci-
 231 See Lawrence O. Gostin, Health of the People: The Highest Law?, 32 J.L. MED. & 
ETHICS 509, 509 (2004). 
 232 See supra notes 112–14 and accompanying text.  For a discussion of the role of 
the FDA in ensuring the safety of prescribed medications, see Barbara A. Noah, Ad-
verse Drug Reactions: Harnessing Experiential Data to Promote Patient Welfare, 49 CATH. U. 
L. REV. 449, 449 (2000). 
 233 Calabro, supra note 83, at 2241. 
 234 The Center for Drug Safety, Facts of the Day, http://www.centerfordrugsafety. 
org/Home_AllFacts.asp (last visited Mar. 21, 2009). 
 235 Id. 
 236 NAT’L COAL. ON HEALTH CARE, FACTS ON HEALTH CARE COSTS 1 (2008), 
http://www.nchc.org/documents/Cost%20Fact%20Sheet-2009.pdf (last visited Mar. 
21, 2009). 
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sion making (that is, to discourage physicians from abdicating their 
valuable role in this decision making).  Patients can and should prop-
erly determine factors such as how valuable a given treatment is to 
them in light of surrounding circumstances, how a proposed treat-
ment plan will disrupt or enhance their life, and the magnitude and 
relative weight of the benefits and risks involved.  Giving physicians a 
legal obligation to resist patient demands for services that are not 
medically indicated does not and should not diminish the role of the 
patient in medical decision making.  It only mandates that physicians 
not abdicate their obligation to ensure that the treatment provided is 
medically indicated. 
VIII.  CONCLUSION 
In a world saturated with medical information through DTCA 
and the Internet, physicians must know how to respond to “in-
formed” patients.  Physicians often face the difficult decision of 
whether to provide a requested treatment that is not medically indi-
cated or risk losing a revenue-generating patient.  Physicians, how-
ever, should not lose sight of their overriding fiduciary obligation to 
promote and protect the best interests of their patients, and they 
should not permit any potential conflicting interest to overcome this 
responsibility, including the possible adverse financial consequences 
to their practice that may result from their refusing a patient’s re-
quest for a given service.  By including within the ambit of the physi-
cian’s fiduciary duty a legal obligation to “say no” to a patient request-
ing services that are not medically indicated, the law empowers 
physicians to exercise their medical judgment, an empowerment that 
best serves us all. 
